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Abstract 
Background: Cardiac Intensive Care Units (CICUs) are understudied, yet are facing a 
growing demand for resources and an aging, increasingly complex patient population. The 
clinical characteristics and outcomes of a very elderly (age ≥80 years) CICU population in the 
United States has never before been described relative to a younger population. A better 
understanding of this patient population could improve the quality of care for patients of all ages 
with critical cardiovascular illness. 
Methods: We retrospectively reviewed a prospectively-collected database of 
consecutive CICU patients admitted to our institution. This included 670 patients from Dec 2012 
to Mar 2014 who were then stratified into 2 groups based upon age: <80 and ≥80 years. 
Demographic, clinical and laboratory characteristics were collected, along with resource use. 
Multiple regression was used to analyze length of stay and mortality during the CICU stay and 
index hospital admission. 
Results: There were significantly more Caucasians in the very elderly cohort (75% vs. 
54%, p<0.001). Comorbidities, admission diagnoses, and rates of interventions were generally 
similar by age. Very elderly patients were significantly less likely to be discharged to home (63% 
vs 85%, p<0.001). Despite significantly higher illness severity scores among patients aged 80 
and older, there were no significant adjusted age-based differences in length of stay nor 
morbidity.  
Conclusion: We found that very elderly CICU patients did not differ significantly in terms 
of cardiovascular risk profile, resource utilization, or short-term mortality, compared to a younger 
cohort of CICU patients. Our findings indicate that age over 80 years alone should not be a 
determining factor when predicting outcomes or making triage and treatment decisions in this 
population. However, our findings need to be replicated beyond a single center to make 
confident conclusions about the wider American CICU population. 
Keywords: “aged, 80 and over”, “patient outcome assessment”, “coronary care unit” 
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1. Introduction 
The American population is aging,1 and the prevalence of cardiovascular disease and 
many of its risk factors is increasing.2 Coupled with rapidly evolving treatment options, the need 
for intensive cardiovascular care is rising. Cardiac Intensive Care Units (CICUs, also known as 
Coronary Care Units (CCUs) or Intensive Coronary Care Units (ICCUs)) are facing a growing 
demand for resources and an increasingly complex patient population.3–7 
However, physicians are often tasked with making ICU triage decisions based on limited 
information, and guidelines cite a paucity of evidence surrounding the importance of age in 
critical care triage.8 Some evidence suggests that elderly patients are rejected from ICU beds 
more often than are younger patients.9 Within the geriatric population, the very elderly 
(octogenarians and nonagenarians) may be particularly vulnerable to age discrimination, but 
very little is known about this CICU population. 
Few studies characterize CICU populations in the United States (US),7,10,11 and the body 
of literature on very elderly patients in the CICU is sparse. To the best of our knowledge, no 
prior study has compared an all-diagnosis (i.e. admitted for a variety of causes) CICU 
population aged 80 years and older to a reference group of younger patients. One study 
described all-diagnosis nonagenarians in a Minnesota CICU12 and found that outcomes were 
comparable to general elderly populations in terms of hospital mortality rate, post-discharge 
survival time, and loss of independence. However, without a reference group, it is difficult to 
assess how very elderly CICU patients fare compared to younger patients. 
 Two studies (from France13 and Brazil14) compared CICU outcomes between patients 
over and under 80 years, and both found higher in-hospital mortality in patients over 80 years. 
However, these studies only included patients admitted for acute coronary syndromes (ACS), 
reducing comparability to octogenarians and nonagenarians admitted to US CICUs for all 
diagnoses. The remaining literature on very elderly CICU patients in the post-stent era (after 
1994) uses a wide variety of inclusion criteria and age cutoffs,15–17 or lacks comparison 
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groups.18–20 Comparing results among studies that differ in country setting and subpopulation is 
a challenge. (See Appendix A for Full Systematic Review.) 
A better understanding of the modern CICU population is crucial to improve quality of 
care and patient outcomes. Knowledge about octogenarian and nonagenarian CICU patients is 
especially limited, yet important considering that the very elderly population is expected to 
increase over time. Clarifying how the very elderly (aged ≥80 years) population differs from 
younger CICU patients will inform decisions about triage and treatment. This study aims to 
characterize a very elderly CICU population at one US tertiary care center, as compared to 
patients younger than 80 years. We will describe demographics, past medical history, clinical 
and laboratory characteristics, resource utilization, and short-term outcomes (CICU and hospital 
mortality). Our goal is to clarify whether very elderly patients treated in the CICU represent a 
higher risk population compared to patients younger than 80 years of age. 
 
2. Methods 
2.1 Study Design and Study Population 
 This retrospective cohort study used a pre-existing database of patients admitted to the 
University of North Carolina (UNC) Hospital CICU in Chapel Hill. UNC Hospital in Chapel Hill is 
a large, academic, urban tertiary care center with a 13-bed CICU for patients with a primary 
cardiovascular diagnosis requiring intensive monitoring.  
Data were collected for a previously-published prospective cohort study investigating the 
effect of moving from an open ICU model of care (different care teams for different patients) to a 
closed model (one physician-led team caring for all patients).21 Trained study personnel 
abstracted chart information on every patient admitted to the CICU during two separate time 
periods: November 1, 2012 to June 30, 2013 (open unit), and September 1, 2013 to March 31, 
2014 (after transition to a closed unit). The time between data collections was intended to 
minimize confounding due to care differences during the transition period. Because other ICUs 
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could use CICU bedspace if needed, patients were excluded if they were managed primarily by 
a surgical team or admitted by a noncardiac service. Patient charts were selected at random for 
cross-abstraction by the original study’s21 principle investigator to check for accuracy. 
 
2.2 Measurements 
Relevant demographic data included the following: age, race, sex, and baseline medical 
characteristics (BMI and past medical history). Admission data included the following: the CICU 
model type (open/closed), primary CICU admission diagnosis, location from which the patient 
was admitted to the CICU, interventions during the patient’s CICU stay, date of hospital 
discharge, and destination at discharge (disposition). All diagnoses are based on ICD-9 codes. 
Several illness severity indicators were collected during the CICU admission: APACHE II (Acute 
Physiology and Chronic Health Evaluation) Score,22 SAPS II (Simplified Acute Physiology 
Score),23 and CAM-ICU (Confusion Assessment Method for ICU Patients) Score.24 The 
APACHE II Score and SAPS II are both predictors of mortality that were validated in general 
medical ICU settings (see Appendix B for full APACHE II and SAPS II scoring systems). The 
CAM-ICU Score tests for delirium in the ICU setting using nonverbal assessment items 
appropriate for mechanically ventilated patients, and is only performed in patients who are not 
too sedated (RASS (Richmond Agitation-Sedation Scale) of -3 or greater). (See Appendix C for 
full CAM-ICU scoring algorhythm).   
 
2.3 Outcomes 
To characterize the ≥80 years and <80 years CICU population, descriptive analysis was 
performed on demographic variables, baseline comorbidities, primary and secondary 
diagnoses, illness severity indicators, and resource use (as indicated by interventions received). 
Our primary outcome variables were CICU mortality and hospital mortality, defined as 
whether or not the patient survived to CICU or hospital discharge, respectively. Hospital 
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mortality included all patients who died in the CICU and outside the CICU, before discharge 
from the index admission. Our secondary outcomes were CICU and hospital length of stay 
(LOS), measured as a continuous outcome (number of days). These secondary outcomes were 
only calculated among those surviving to CICU or hospital discharge, respectively.  
 
2.4 Statistical Analysis 
 Descriptive statistics are presented as medians with inter-quartile ranges for continuous 
variables (as appropriate for distribution), or as percentages for categorical or continuous 
variables. Significant age-based differences in descriptive variables were tested using the 
Wilcoxon Rank-Sum Test for continuous variables, and Pearson’s Chi-Squared Test or Fisher’s 
Exact Test (as appropriate for the number of observations) for categorical and dichotomous 
variables.  
 Univariate and multivariable logistic regression was used to test for differences in CICU 
and hospital mortality between the ≥80 and <80 age groups. Univariate and multivariable linear 
regression were used to test for differences in LOS between the ≥80 and <80 age groups. 
Models were reduced by individually removing insignificant non-demographic covariates, 
keeping them in the model if the age-associated coefficient or odds ratio changed by a 
predetermined threshold of ≥10%. Predicted probabilities were calculated using marginal 
effects. 
All reported p-values are 2-sided. Statistical significance was set at the 95% confidence 
level and defined as p>0.05. Data were analyzed in STATA (STATA/SE 15.1 for Mac, 
StataCorp, College Station, TX).  
 
2.5 Choice of Model Covariates & Sensitivity Analyses 
 Covariates were selected a priori based on their predicted association with both mortality 
and age. These included sex, race, BMI, illness severity score (SAPS II and APACHE II), and 
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key comorbidities: coronary artery disease (CAD), congestive heart failure (CHF), and end-
stage renal disease (ESRD). We also included ICU model (open versus closed) as a potential 
confounder since this variable changed during our data collection period. 
We controlled for illness severity using SAPS II without the age component of the score. 
Age was removed to avoid controlling for this variable twice. SAPS II was selected over the 
APACHE II Score because it allowed assessment of individual comorbidities’ mortality 
contribution (which APACHE II precludes because it incorporates ESRD and CHF). Age-
adjusted SAPS II was calculated by subtracting the appropriate number of points from the 
original SAPS II based on each patient’s age. Univariate regressions were performed using both 
SAPS II and age-adjusted SAPS II to identify major differences, which might indicate reasons to 
doubt the adjusted score’s ability to predict mortality.  
 The sample size and prevalence of main outcomes limited our number of covariates that 
would be statistically appropriate to include in our models. Given the lack of literature on this 
topic, however, we tested several additional comorbidities for their potential role in the age-
mortality relationship in critical cardiovascular illness: diabetes mellitus (DM), chronic lung 
disease (CLD), cerebrovascular accident (CVA), and ICU delirium. These additional methods 
and results are included in Appendix D.  
 To indicate whether any results might be spurious simply due to the dichotomized form 
of age, a second sensitivity analysis tested alternative age configurations: quadratic (years2) 
and spline (continuous years). The spline model handles age as a continuous variable, but 
calculates separate odds ratios for pre-defined sections along the age spectrum. Four spline 
sections were defined (age <40, 40-60, 60-80, and ≥80 years). Results of these analyses are 
presented in Appendix E.  
Finally, because SAPS II as the sole indicator of illness severity may not distinguish 
between types of critically ill patients, we additionally modeled hospital mortality among 5 
subpopulations who may indicate the “sickest of the sick” (cardiac arrest, cardiogenic shock, or 
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intubated) and the hemodynamically unstable (requiring inotropes or vasopressors). Pearson’s 
Chi-Squared and Fisher’s Exact Tests were used to search for significant unadjusted age-based 
mortality. Logistic regression to adjust for confounders was used for cases with significant age-
based differences and adequate subpopulation size (>10 patients in each group).  
 
3. Results 
3.1 Patient Demographics and Baseline Medical Characteristics 
 A total of 670 patients aged 16 to 100 years were included in our study population. 
Ninety-three patients were aged 80 years or older. Compared to younger patients, those ≥80 
years had lower BMI and a larger proportion were female. The study population was 
predominantly white, especially among those ≥80 years (75.3%). 
 Older patients were significantly more likely to have a history of severe valvular disease 
or leukemia, and less likely to have a history of diabetes or chronic lung disease. There were no 
other significant differences in comorbidities (Table 1). 
 
3.2 Admission, Discharge, and Illness Severity 
 Very elderly patients were significantly more likely to have conduction disease but less 
likely to have arrhythmia. The data suggests that CICU admissions for cardiac arrest (especially 
ventricular fibrillation/ventricular tachycardia arrest) and acute valve disease are more common 
in the ≥80 population, although differences were not statistically significant. Rates of primary 
admission diagnoses were otherwise similar between groups (Table 2).  
 A substantial number of patients fell into the “other” category of primary CICU diagnosis. 
The most common diagnosis in this category for both age groups was hardware-related 
diagnoses (malfunction, infection, or placement of pacemaker or implantable cardiac 
defibrillator) followed by Takotsubo Cardiomyopathy. See Appendix F for details of diagnoses in 
this category. 
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 Very elderly patients had significantly higher APACHE II and SAPS II scores, while the 
age-adjusted SAPS II Score was insignificantly higher in older patients. Delirium during the 
CICU stay was more common in patients ≥80 years, although this trend was insignificant 
(25.9% vs 19.4%, p=0.18) (Table 3). 
 There were no statistically significant differences in secondary discharge diagnoses. 
Among patients who survived to discharge, very elderly patients were less likely to be 
discharged home and more likely to be discharged to a rehabilitation or skilled nursing facility 
(Table 2). 
 
3.3 Resource Use  
 During their CICU stay, those ≥80 years were significantly more likely to receive a 
pacemaker or temporary pacer, and less likely to receive a diagnostic catheterization. Resource 
use was otherwise not significantly different by age (Table 4). 
	 12	
	
Table 1: Descriptive Statistics of Baseline Characteristics 
Variable Overall Sample Age <80 Age 80+ p-value* 
 
Continuous 
 
N 
 
Median(IQR) 
  
N 
 
Median(IQR)  
  
N 
 
Median(IQR)  
 for age-based 
difference 
Age (years) 670 64 (55-73)  577 62 (53-79)  93 84 (82-86)  <0.001 
BMI (kg/m2) 670 28.3 (24.4-33.3)  577 28.9 (24.6-34.2)  93 25.1 (22.4-29.2)  <0.001 
Categorical N %   N %   N %   p-value** 
Female Sex 258 38.5   216 37.4  42 45.2  0.16 
Race 
White 
 
380 
 
56.7 
  
310 
 
53.7 
  
70 
 
75.3 
 0.002§ 
<0.001 
Black 199 29.7  183 31.7  16 17.2  0.004 
Hispanic 1 0.2  1 0.2  0 0.0  1.00§ 
Asian 7 1.0  6 1.0  1 1.0  1.00§ 
Other or Not 
Documented 
83 12.4  77 13.3  6 6.5  0.06 
History of: 
   HTN 
 
456 
 
68.1 
  
400 
 
69.3 
  
56 
 
60.2 
  
0.08 
   HLD 305 45.5  254 44.0  51 54.8  0.05 
   CAD 347 51.8  295 51.1  52 55.9  0.39 
   MI 200 29.9  171 29.6  29 31.2  0.76 
   PCI 133 19.9  114 19.9  19 20.4  0.88 
   CABG 90 13.4  72 12.5  18 19.4  0.07 
CHF 
   HFrEF 
   HFpEF 
338 
250 
54 
50.5 
37.3 
10.8 
 293 
220 
44 
50.8 
38.1 
7.6 
 45 
30 
10 
48.4  
32.3 
10.8 
 0.67 
0.28 
0.30 
LVAD 14 2.1  13 2.3  1 1.1  0.71§ 
ICD/PPM 137 20.5  119 20.6  18 19.4  0.78 
Severe Valvular   
   Disease 
49 7.3  37 6.4  12 12.9  0.03 
Congenital Heart     
   Disease 
8 1.2  7 1.2  1 1.1  1.00§ 
CVA 79 11.8  68 11.8  11 11.8  0.99 
DM 240 35.8  226 39.2  14 15.1  <0.001 
CKD 160 23.9  133 23.1  27 29.0  0.21 
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ESRD 51 7.6  48 8.3  3 3.2  0.09§ 
Liver Disease 35 5.2  33 5.7  2 2.2  0.21§ 
CLD 151 22.5  138 23.9  13 14.0  0.03 
Pulmonary HTN 52 7.8  43 7.5  9 9.7  0.46 
Cancer within  
5 years 
68 10.2  51 8.8  17 18.3  0.005 
   Lymphoma 3 0.5  2 0.4  1 1.1  0.36§ 
   Leukemia 6 0.9  2 0.4  4 4.3  0.004§ 
   Solid Tumor 59 8.8  48 8.3  11 11.8  0.27 
PVD 65 9.7  56 9.7  9 9.7  0.99 
CTD 1 0.2  1 0.2  0 0.0  1.00§ 
PUD 10 1.5  7 1.2  3 3.2  0.15§ 
HTN = Hypertension. HLD = Hyperlipidemia. CAD = Coronary Artery Disease. MI = Myocardial Infarction. PCI = percutaneous 
coronary intervention. CABG = coronary artery bypass graft. CHF = Congestive Heart Failure. HFrEF = Heart Failure with reduced 
Ejection Fraction. HFpEF = Heart Failure with preserved Ejection Fraction. LVAD = Left ventricular assistive device. ICD/PPM = 
Implantable Cardiac Defibrillator or Pacemaker. CVA = Cerebral Vascular Accident. DM = Diabetes Mellitus. CKD = Chronic Kidney 
Disease. ESRD = End-Stage Renal Disease. CLD = Chronic Lung Disease. PVD = peripheral vascular disease. CTD = connective 
tissue disease. PUD = peptic ulcer disease. 
* = 2-sided p-value, calculated using Wilcoxon Rank Sum test for difference in medians between Age <80 and Age 80+ 
** = 2-sided p-value, calculated using Pearson’s Chi-Squared Test of Independence, comparing Age <80 to Age 80+, unless noted 
by § 
§ = 2-sided p-value, calculated using Fisher’s Exact Test of Independence, comparing Age <80 to Age 80+
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Table 2: Descriptive Statistics of Primary and Secondary Diagnoses 
 
 
Primary Diagnosis 
Overall Sample 
N=670 
 
N (%) 
Age <80 
N=577 
 
N (%) 
Age ≥80 
N=93 
 
N (%) 
p-value* 
for age-
based 
difference 
STEMI 79 (11.8) 68 (11.8) 11 (11.8) 0.99 
NSTEMI 101 (15.1) 89 (15.4) 12 (12.9) 0.53 
Acute Heart Failure 77 (11.5) 64 (11.1) 13 (14.0) 0.42 
Cardiogenic Shock 87 (13.0) 76 (13.2) 11 (11.8) 0.72 
Acute Combined HF + CS 164 (24.5) 140 (24.3) 24 (25.8) 0.75 
Any Cardiac Arrest 
   VF/VT 
   PEA/Asystole 
53 (7.9) 
12 (1.8) 
41 (6.1) 
42 (7.3) 
8 (1.4) 
34 (5.9) 
11 (11.8) 
4 (4.3) 
7 (7.5) 
0.13 
0.07§ 
0.54 
Arrhythmia 67 (10.0) 66 (11.4) 1 (1.1) 0.001§ 
Conduction Disease 25 (3.7) 16 (2.8) 9 (6.7) 0.001 
Acute Valve Disease 13 (1.9) 9 (1.6) 4 (4.3) 0.09§ 
Tamponade or Effusion 17 (2.5) 14 (2.4) 3 (3.2) 0.72§ 
Acute Hypertension 23 (3.4) 21 (3.6) 2 (2.2) 0.76§ 
Acute Respiratory Failure 17 (2.5) 14 (2.4) 3 (3.2) 0.72§ 
DVT or PE 4 (0.6) 4 (0.7) 0 (0.0) 1.00§ 
Heart Transplant Rejection 7 (1.0) 7 (1.2) 0 (0.0) 0.60§ 
LVAD Complication 9 (1.3) 8 (1.4) 1 (1.1) 1.00§ 
Sepsis or Infection 29 (4.3) 24 (4.2) 5 (5.4) 0.59 
Other 62 (9.3) 55 (9.5) 7 (7.5) 0.54 
Other Diagnoses at Discharge  
N (%) 
 
N (%) 
 
N (%) 
 
p-value* 
Acute Respiratory Failure 57 (8.5) 51 (8.8) 6 (6.5) 0.44 
Acute Renal Failure 103 (15.4) 85 (14.7) 18 (19.4) 0.25 
Sepsis 21 (3.1) 19 (3.3) 2 (2.2) 0.76§ 
Pneumonia 18 (2.7) 17 (3.0) 1 (1.1) 0.49§ 
Anoxic Brain Injury 4 (0.6) 3 (0.5) 1 (1.1) 0.45§ 
Cardiac Arrest 16 (2.4) 16 (2.8) 0 (0.0) 0.15§ 
DVT or PE 25 (3.7) 23 (4.0) 2 (2.2) 0.56§ 
Acute Bleed (non-intracerebral) 14 (2.1) 11 (1.9) 3 (3.2) 0.43§ 
Cardiogenic Shock 20 (3.0) 20 (3.5) 0 (0.0) 0.09§ 
Acute HFrEF or HFpEF    
   Exacerbation 
41 (6.1) 36 (6.2) 5 (5.4) 0.75 
CVA (ischemic or hemorrhagic)  
   or TIA 
15 (2.2) 14 (2.4) 1 (1.1) 0.71§ 
Acute Liver Injury 6 (0.9) 6 (1.0) 0 (0.0) 0.32 
Acute Heart Transplant Rejection 3 (0.5) 0 (0.0) 3 (0.5) 0.49 
* = 2-sided p-value, calculated with Pearson’s Chi-Squared Test of Independence, comparing 
Age <80 to Age 80+, unless noted by § 
§ = 2-sided p-value, calculated with Fisher’s Exact Test of Independence, comparing Age <80 to 
Age 80+ 
STEMI = ST-segment Elevation Myocardial Infarction. NSTEMI = non-ST-segment Elevation 
Myocardial Infarction. HF = Heart Failure. CS = Cardiogenic Shock. VF/VT = Ventricular 
Fibrillation / Ventricular Tachycardia. PEA = Pulseless Electrical Activity. DVT = Deep Vein 
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Thrombosis. PE = Pulmonary Embolism. LVAD = Left Ventricular Assistive Device. TIA = 
Transient Ischemic Attack.  
 
 
Table 3: Descriptive Statistics of Admission Severity and Type 
 
 
Illness Severity 
Scores 
Overall Sample 
N=670 
 
Median (IQR) 
Age <80 
N=577 
 
Median (IQR) 
Age≥80 
N=93 
 
Median (IQR) 
p-value* 
for age-
based 
difference 
APACHE II Score 14 (9-22) 14 (9-21) 17 (11-28) 0.0004 
SAPS II Score 34.4 (18.2) 32.9 (17.8) 43.4 (18.1) <0.0001 
Adjusted SAPS II  
 Score without age 
23.3 (17.2) 22.9 (17.1) 25.4 (18.1) 0.18 
Delirium Status N=591 N=510 N=81 p-value** 
CAM ICU  
Positive 
120 (20.3) 
 
99 (19.4) 
 
21 (25.9) 
 
0.18 
Admission Type N=669 N=576 N=93 p-value§ 
Admitted from: 
   ED 
   OSH Transfer 
   Outpatient Clinic 
   Inpatient Floor 
   OR/Cath Lab 
 
182 (27.2) 
195 (29.2) 
29 (4.3) 
260 (38.9) 
3 (0.5) 
 
151 (26.2) 
173 (30.0) 
23 (4.0) 
226 (39.2) 
3 (0.5) 
 
31 (33.3) 
22 (23.7) 
6 (6.5) 
34 (6.5) 
0 (0.0) 
0.36 
 
ICU Type  
   (open or closed) 
N=670 N=577 N=93 p-value** 
Closed Unit 338 (50.5) 291 (50.4) 47 (50.5) 0.99 
Disposition N=571 N=496 N=75 p-value** 
Discharged to: 
   Home 
   Rehab/SNF 
   Hospice 
   Psych 
   Acute Care   
     Facility/other  
     Inpatient Unit 
 
466 (81.6) 
73 (12.8) 
23 (4.0) 
2 (0.4) 
7 (1.2) 
 
419 (84.5) 
50 (10.1) 
20 (4.0) 
2 (0.4) 
5 (1.0) 
 
47 (62.7) 
23 (30.7) 
3 (4.0) 
2 (2.7) 
0 (0.0) 
<0.001 
<0.001 
<0.001 
1.00§ 
1.00§ 
0.25§ 
*= 2-sided p-value, calculated using Wilcoxon Rank Sum test for difference in medians between 
Age <80 and Age 80+ 
** = 2-sided p-value, calculated using Pearson’s Chi-Squared Test of Independence, comparing 
Age <80 to Age 80+ 
§ = 2-sided p-value, calculated using Fisher’s Exact Test, comparing Age<80 to Age 80+ 
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Table 4: Interventions Received during CICU Admission 
Intervention Overall 
Sample 
N=670 
 
N(%) 
Age <80 
N=577 
 
 
N(%) 
Age ≥80 
N=93 
 
 
N (%) 
p-value for age-
based 
difference* 
Diagnostic 
Catheterization 
249 (37.2) 224 (38.8) 25 (26.9) 0.03 
PCI 148 (22.1) 132 (22.9) 16 (17.2) 0.22 
Nuclear Stress Test 9 (1.3) 8 (1.4) 1 (1.1) 1.00§ 
Cardiac MRI 6 (1.0) 0 (0.0) 6 (0.9) 1.00§ 
CABG 15 (2.2) 13 (2.3) 2 (2.2) 1.00§ 
Central Line 165 (24.6) 137 (23.7) 28 (30.1) 0.19 
Arterial Line 169 (25.2) 148 (25.7) 21 (22.6) 0.53 
Pulmonary Artery 
Catheter 
145 (21.6) 129 (22.4) 16 (17.2) 0.26 
Inotropes 106 (15.8) 90 (15.6) 16 (17.2) 0.69 
Vasopressors 142 (21.2) 120 (20.8) 22 (23.7) 0.53 
IABP 34 (5.1) 31 (5.4) 3 (3.2) 0.61§ 
Temporary LVAD 1 (0.2) 1 (0.2) 0 (0.0) 1.00§ 
LVAD Implant 18 (2.7) 17 (13.0) 1 (1.1) 0.49§ 
ECMO 6 (0.9) 6 (1.0) 0 (0.0) 1.00§ 
Mechanical Ventilation 
 Invasive 
  Non-Invasive  
 
149 (22.2) 
50 (7.5) 
 
128 (22.2) 
41 (7.1) 
 
21 (22.6) 
9 (9.7) 
 
0.93 
0.38 
Echocardiogram 538 (80.3) 465 (80.6) 73 (78.5) 0.64 
TEE 18 (2.7) 15 (2.6) 3 (3.2) 0.73§ 
Antiarrhythmic Drug 133 (19.9) 120 (20.8) 13 (14.0) 0.13 
Temporary Pacer 4 (0.6) 1 (0.2) 3 (3.2) 0.009§ 
PPM Implant 30 (4.5) 20 (3.5) 10 (10.7) 0.002 
ICD 27 (4.0) 22 (3.8) 5 (3.4) 0.48 
Ablation 31 (4.6) 30 (5.2) 1 (1.1) 0.11§ 
DC Cardioversion / 
Defibrillation 
40 (6.0) 32 (5.6) 8 (8.6) 0.25 
Therapeutic 
Hypothermia 
21 (3.1) 17 (3.0) 4 (4.3) 0.52§ 
Valve Surgery 4 (0.6) 3 (0.5) 1 (1.1) 0.45§ 
Dialysis 36 (5.4) 35 (6.1) 1 (1.1) 0.05§ 
Bronchoscopy 5 (0.8) 3 (0.5) 2 (2.2) 0.14§ 
Endoscopy 16 (2.4) 15 (2.6) 1 (1.1) 0.71§ 
Thoracentesis 11 (1.6) 11 (1.9) 0 (0.0) 0.38§ 
Paracentesis 2 (0.3) 2 (0.4) 0 (0.0) 1.00§ 
Pericardiocentesis 19 (2.8) 15 (2.6) 4 (4.3) 0.32§ 
Chest Tube 72 (10.8) 64 (11.1) 8 (8.6) 0.47 
Lumbar Puncture 2 (0.3) 1 (0.2) 1 (1.1) 0.26§ 
* = 2-sided p-value, calculated using Pearson’s Chi-Squared Test of Independence, comparing 
Age <80 to Age 80+ 
§ = 2-sided p-value, calculated using Fisher’s Exact Test, comparing Age<80 to Age 80 
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3.4 Length of Stay 
Five-hundred and ninety-three patients survived to CICU discharge. Among survivors, 
the average CICU LOS was 4.1 days (SD 5.4) for the entire study population, 4.2 days (SD 5.6) 
for the 514 CICU survivors younger than 80 years of age, and 3.4 days (SD 3.5) for the 79 
CICU survivors aged ≥80 years. There was no significant difference in CICU LOS by age. Non-
white patients stay about 1 day longer in the CICU (coefficient 0.96, 95% CI 10-1.81). Staying in 
a closed unit ICU, increasing SAPS II Score and history of CHF were also associated with 
significantly longer CICU admissions (Table 5). 
Five-hundred and seventy-two patients survived to hospital discharge. Two of these 
patients (both <80 years) were missing discharge dates and were excluded from hospital LOS 
analysis. Of the 570 patients included in our analysis of hospital LOS, 75 were ≥80 years. The 
average hospital LOS (among all survivors) was 8.9 days (SD 11): 9.3 days (SD 12) for patients 
<80 years, and 7.7 days (SD 8) for those ≥80.  
Older age was associated with shorter hospital LOS (-2.13 days, 95% CI -4.65 to 0.40; p 
= 0.10), although the difference was not statistically significant. With the exception of race, 
independent predictors of longer hospital LOS were similar to those of CICU LOS and included: 
staying in a closed-model CICU (3.08 more days in the hospital), history of CHF (5.3 more 
days), and more severe illness as measured by age-adjusted SAPS II (2.0 more days for each 
10-point increase) (Table 6). 
 
3.5 CICU Mortality 
Overall, 14 patients ≥80 years (15.1%) and 63 patients <80 years (10.9%) died in the 
CICU. There was no significant age-based difference in odds of CICU mortality on univariate or 
multivariable regression (Table 7). Using the fully adjusted model, patients ≥80 have an 11.8% 
(95% CI 6.9-17.0%) predicted probability of CICU mortality compared to 11.4% (95% CI 9.2-
13.6%) predicted mortality among younger patients. The only independent predictor of CICU 
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mortality in our model was increasing age-adjusted SAPS II score (each 1-point increase is 
associated with 1.08 (1.07-1.10) times the odds of CICU mortality, while holding all other 
variables equal) (Table 7). 
 
5.6 Hospital Mortality 
 Eighteen patients ≥80 years (19.4%) died in the hospital compared to 80 patients <80 
years (13.9%). We found no significant difference in hospital mortality between the age groups 
(Table 8). Patients ≥80 years had 1.21 times the odds of hospital mortality (95% CI 0.60-2.45, 
p=0.60) compared to younger patients, and a predicted probability of hospital mortality of 16.2% 
(95% CI 10.3-22.2%) compared to 14.3% (95% CI 11.9-16.7%) among younger patients (Figure 
1). Figure 2 shows that patients across the spectrum of SAPS II severity do not have different 
hospital mortality rates by age. Reducing the model accordingly did not significantly change 
model fit nor age-based odds ratio. Holding other variables constant, sex and age-adjusted 
SAPS II score were significant independent predictors of mortality. Men had lower odds of 
hospital mortality (OR 0.58, 95% CI 0.34-0.99, p=0.05) and each 1-point increase in SAPS II 
was associated with 1.08 times the odds of hospital mortality (Table 8). 
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Table 5: CICU Length of Stay: Univariate and Multivariable Models (among CICU survivors, n=593) 
Variable Univariate Full Model Reduced Model 
 Coefficient p Coefficient p Coefficient p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
0.82 (-2.09-0.45) 
 
 
0.21 
 
-- 
-0.68 (-1.92-0.57) 
 
 
0.28 
 
-- 
-0.66 (-1.90-0.57) 
 
 
0.29 
Sex 
   Female (ref) 
   Male 
 
-- 
-0.17 (-1.07-0.72) 
 
 
0.70 
 
-- 
-0.30 (-1.17-0.57) 
 
 
0.50 
 
-- 
-0.30 (-1.15-0.56) 
 
 
0.49 
BMI (per kg/m2) 0.03 (-0.03-0.09) 0.29 -0.001 (-0.06-0.05) 0.97 -0.001 (-0.06-0.05) 0.97 
Race 
   White (ref) 
   Non-white 
 
-- 
1.67 (0.81-2.53) 
 
 
<0.001 
 
-- 
0.97 (0.10-1.85) 
 
 
0.03 
 
-- 
0.96 (0.10-1.81) 
 
 
0.03 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.52 (-0.35-1.38) 
 
 
0.24 
 
-- 
0.98 (0.15-1.82) 
 
 
0.02 
 
-- 
0.98 (0.15-1.82) 
 
 
0.02 
SAPS II Score  
   (per 1 unit) 
0.08 (0.05-0.10) <0.001  
 
   
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
0.09 (0.06-0.12) <0.001 0.08 (0.05-0.11) <0.001 0.08 (0.05-0.11) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
0.12 (-0.74-0.99) 
2.22 (1.38-3.07) 
1.08 (-0.64-2.81) 
 
0.78 
<0.001 
0.22 
 
0.03 (-0.84-0.90) 
1.95 (1.10-2.81) 
-0.28 (-1.96-1.40) 
 
0.95 
<0.001 
0.75 
 
 
1.95 (1.12-2.79) 
 
 
<0.001 
Constant   0.80 0.44 0.81 0.41 
Adjusted  
   R-Squared 
  0.10  0.10  
BMI = Body Mass Index. CAD = Coronary Artery Disease. CHF = Congestive Heart Failure.  
ESRD = End-stage Renal Disease. 
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Table 6: Hospital Length of Stay: Univariate and Multivariable Models (among hospital survivors, n=570) 
Variable Univariate Full Model Reduced Model 
 Coefficient p Coefficient p Coefficient p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
-2.21 (-4.86-0.44) 
 
 
0.10 
 
-- 
-2.28 (-4.81-0.25) 
 
 
0.08 
 
-- 
-2.13 (-4.65-0.40) 
 
 
0.10 
Sex 
   Female (ref) 
   Male 
 
-- 
0.58 (-1.27-2.44) 
 
 
0.62 
 
-- 
0.08 (-1.69-1.85) 
 
 
0.93 
 
-- 
-0.13 (-1.88-1.62) 
 
 
0.89 
BMI (per kg/m2) 0.03 (-0.09-0.15) 0.63 -0.03 (-0.15-2.38) 0.56 -0.02 (-0.13-0.09) 0.70 
Race 
   White (ref) 
   Non-white 
 
-- 
2.41 (0.60-4.21) 
 
 
0.009 
 
-- 
0.61 (-1.16-2.38) 
 
 
0.50 
 
-- 
0.74 (-1.00-2.48) 
 
 
0.41 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
1.60 (-0.19-3.39) 
 
 
0.08 
 
-- 
3.21 (1.50-4.92) 
 
 
<0.001 
 
-- 
3.08 (1.37-4.79) 
 
 
<0.001 
SAPS II Score  
   (per 1 unit) 
0.17 (0.10-0.23) 
 
<0.001  
 
   
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
0.20 (0.14-0.28) <0.001 0.21 (0.14-0.27) <0.001 0.20 (0.13-0.26) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
-0.31 (-2.10-1.49) 
5.83 (4.10-7.56) 
0.68 (-2.91-4.28) 
 
0.74 
<0.001 
0.71 
 
-1.29 (-3.06-0.47) 
5.60 (3.87-7.34) 
-2.51 (-5.95-0.94) 
 
0.15 
<0.001 
0.15 
 
 
5.33 (3.62-7.03) 
 
 
<0.001 
Constant   2.35 0.27 1.64 (-2.42-5.70) 0.43 
Adjusted  
   R-Squared 
  0.14  0.13  
BMI = Body Mass Index. CAD = Coronary Artery Disease. CHF = Congestive Heart Failure.  
ESRD = End-stage Renal Disease. 
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Table	7:		CICU Mortality Univariate and Multivariable Models	
Variable Univariate Full Model Reduced Model 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
1.45 (0.77-2.70) 
 
 
0.25 
 
-- 
1.05 (0.48-2.29) 
 
 
0.90 
 
-- 
1.08 (0.50-2.33) 
 
 
0.84 
Sex 
   Female (ref) 
   Male 
 
-- 
0.87 (0.53-1.40) 
 
 
0.56 
 
-- 
0.75 (0.42-1.36) 
 
 
0.34 
 
-- 
0.80 (0.45-1.43) 
 
 
0.45 
BMI (per kg/m2) 0.99 (0.96-1.02) 0.40 0.97 (0.93-1.01) 0.16 0.96 (0.93-1.00) 0.08 
Race 
   White (ref) 
   Non-white 
 
-- 
0.87 (0.54-1.41) 
 
 
0.57 
 
-- 
0.76 (0.41-1.42) 
 
 
0.39 
 
-- 
0.74 (0.41-1.34) 
 
 
0.32 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.75 (0.47-1.21) 
 
 
0.24 
 
-- 
0.84 (0.47-1.52) 
 
 
0.57 
 
 
 
 
SAPS II Score  
   (per 1 unit) 
1.08 (1.06-1.10) <0.001     
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
1.08 (1.06-1.10) <0.001 1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 
History of: 
   CAD 
   CHF  
   ESRD 
 
1.20 (0.75-1.94) 
0.90 (0.56-1.44) 
2.30 (1.13-4.71) 
 
0.45 
0.66 
0.02 
 
1.59 (0.86-2.92) 
1.02 (0.56-1.86) 
1.36 (0.56-3.29) 
 
0.14 
0.95 
0.50 
  
Constant   0.028 <0.001 0.038 <0.001 
Pseudo R2   0.31  0.30  
BMI = Body Mass Index. CAD = Coronary Artery Disease. CHF = Congestive Heart Failure.  
ESRD = End-stage Renal Disease. 
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Table 8: Hospital Mortality Univariate and Multivariable Models 
Variable Univariate Full Model Reduced Model 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
1.49 (0.85-2.63) 
 
 
0.17 
 
-- 
1.21 (0.60-2.45) 
 
 
0.60 
 
-- 
1.24 (0.61-2.49) 
 
 
0.56 
Sex 
   Female (ref) 
   Male 
 
-- 
0.70 (0.45-1.08) 
 
 
0.10 
 
-- 
0.58 (0.34-0.99) 
 
 
0.05 
 
-- 
0.60 (0.35-1.01) 
 
 
0.06 
BMI (per kg/m2) 1.00 (0.98-1.03) 0.89 0.99 (0.95-1.02) 0.50 0.99 (0.95-1.02) 0.47 
Race 
   White (ref) 
   Non-white 
 
-- 
1.03 (0.67-1.58) 
 
 
0.90 
 
-- 
0.94 (0.54-1.64) 
 
 
0.83 
 
-- 
0.91 (0.54-1.55) 
 
 
0.74 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
1.08 (0.70-1.65) 
 
 
0.73 
 
-- 
1.45 (0.85-2.47) 
 
 
0.17 
 
 
 
 
SAPS II Score  
   (per 1 unit) 
1.08 (1.07-1.10) <0.001  
 
   
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
1.11 (0.72-1.71) 
0.93 (0.61-1.43) 
1.91 (0.96-3.79) 
 
0.62 
0.75 
0.07 
 
1.46 (0.84-2.54) 
1.09 (0.63-1.88) 
0.98 (0.42-2.31) 
 
0.18 
0.76 
0.96 
  
Constant   0.019  <0.001 0.031  <0.001 
Pseudo R2   0.30  0.29  
BMI = Body Mass Index. CAD = Coronary Artery Disease. CHF = Congestive Heart Failure.  
ESRD = End-stage Renal Disease.
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Figure 1: Predicted Probability of Hospital Mortality by Age (adjusted for sex, BMI, race, 
age-adjusted SAPS II Score, ICU model type, and history of CAD, CHF and ESRD). 
 
 
Figure 2: Predicted Probability of Hospital Mortality by Age and age-adjusted SAPS II 
Score 
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5.7 Hospital Mortality by Sub-Population 
 Among the invasively mechanically intubated CICU population, patients ≥80 years had 
3.16 times the odds of dying compared to those <80, while controlling for BMI and SAPS II 
score (OR 3.16, 95% CI 1.07-9.27, p=0.04). Very elderly hemodynamically unstable patients 
requiring vasopressors had a higher hospital mortality rate, although the difference was not 
statistically significant. There were no significant mortality differences between the age groups 
among other critically ill subpopulations, although sample size was very low for many of the 
subpopulations.  
Table 9: Hospital Mortality by Age within Subpopulations of Critically Ill 
Subpopulation Total N N (%) who 
died 
Significance 
of Difference 
by Age: 
p-value** 
OR (95% CI)***        p-value 
(if appropriate) 
Primary Diagnosis     
CS or Acute 
Combined HF & 
CS* 
   Age <80 (ref) 
   Age ≥80 
179  
 
 
29 (18.7) 
3 (12.5) 
0.58§  
Any Cardiac Arrest 
   Age <80 (ref) 
   Age ≥80 
53  
30 (71.4) 
9 (81.8) 
0.49  
Interventions 
Indicating Severe 
Illness 
    
Inotropes 
   Age <80 (ref) 
   Age ≥80 
106  
20 (22.2) 
5 (31.6) 
0.43  
Vasopressors 
   Age <80 (ref) 
   Age ≥80 
142  
43 (35.8) 
12 (54.6) 
0.10  
Invasive Mechanical 
Ventilation 
   Age <80 (ref) 
   Age ≥80 
149  
 
51 (39.8) 
15 (71.4) 
0.007  
 
           -- 
3.16 (1.07-9.27)        0.04 
* = primary or secondary diagnosis of cardiogenic shock (CS) or acute combined cardiogenic 
shock and heart failure (HF) 
** = calculated using 2-sided Pearson’s Chi-Squared Test of Independence unless noted by § 
§ = calculated using 2-sided Fisher’s Exact Test of Independence 
*** = adjusted for BMI & SAPS II Score without Age Component 
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4. Discussion  
4.1 Characterization of Study Population  
At baseline, the fact that very elderly patients tend to be more female and white is 
consistent with longer life expectancies among these demographics25 in the US, and agrees 
with international gender trends observed in all known studies comparing CICU populations 
≥8013,14 or ≥75 years15,16,26,27 to younger ages. Our very elderly population’s significantly higher 
rate of valvular disease is consistent with a well-established association with age in the 
American population28.  
Our study’s very elderly population had no clear pattern of increased or decreased risk 
for cardiovascular disease, and had similar rates of risk factor sequelae such as CAD, 
myocardial infarction, percutaneous coronary intervention, CHF and CVA. Aside from the risk 
associated with age and female sex, our very elderly population had higher lipids, yet lower 
blood pressure and BMI. By contrast, a French ≥80 CICU population with ACS had higher blood 
pressure and lower lipids.13 It is interesting that the older age group tended to have less DM and 
ESRD, yet more chronic kidney disease (CKD). This seemingly contradictory trend is consistent 
with high mortality rates associated with DM and ESRD,29 CKD’s high prevalence among 
Americans over 70 years,30 and a lack of association between increasing age and CKD 
complications (including ESRD).31 French and Brazilian very elderly CICU patients with ACS did 
not have different prevalences of diabetes than younger patients13,14  but there is no US-based 
data with which to compare our results. Our study notably lacks data on lifestyle risk factors, 
such as exercise or smoking.  
The very elderly were admitted for similar reasons compared to younger patients. The 
most common admission diagnosis in both groups was acute combined heart failure and 
cardiogenic shock, consistent with a study of nonagenarian CICU patients in Minnesota which 
cited acute decompensated heart failure as the most common reason for CICU admission.  
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Our very elderly patients had significantly higher illness severity scores, and SAPS II 
overestimated mortality in both age groups. An important consideration is that neither SAPS II 
nor APACHE II were developed and validated in a CICU population.22,23 However, SAPS II was 
previously found to be appropriate for the CICU population,32 and age-adjusted SAPS II 
remained a significant independent predictor of mortality and LOS. Thus, we believe SAPS II 
and age-adjusted SAPS II were both adequate indicators of illness severity in our study 
population. Adjusting SAPS II removed the significance of age-based illness severity 
differences, but retained the trend that very elderly patients had higher scores. This suggests 
that age may have been a major driver behind the very elderly’s higher SAPS II scores, but 
these patients still tend to have “worse” clinical and laboratory parameters on CICU admission, 
even when not considering age.  
According to the interventions measured in our study, resource use was generally similar 
by age. However, interpretation of these numbers must consider that we do not have 
information on the priorities of care and do-not-resuscitate/do-not-intubate preferences of each 
group, nor is this study equipped to ask whether each age group received the appropriate 
resources for their clinical conditions. The very elderly’s significantly higher rate of temporary 
and permanent pacemakers is consistent with their significantly higher rate of conduction 
disease. It is interesting that patients ≥80 years received significantly fewer diagnostic 
catheterizations despite similar rates of heart failure, and received slightly fewer percutaneous 
coronary interventions (PCIs) despite equal rates of ST-segment elevation myocardial infarction 
(STEMI). The difference in PCI may reflect a high prevalence of atypical ACS symptoms in the 
very elderly33 and longer prehospital delays in elderly STEMI patients,16,34 potentially excluding 
PCI as a possible treatment option more often. Austruy and colleagues also found that French 
CICU patients ≥80 years with ACS were less likely to receive PCI, but were more likely to 
receive multiple stents.13 Importantly, rates of invasive mechanical intubation and intra-aortic 
balloon pump (IABP) placement were not different by age in our population. A recent study in 
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NYC identified the need for invasive mechanical ventilation and IABP in CICU patients as an 
independent predictors of mortality.10 
 
4.2 Length of Stay 
Older patients have similar, and possibly even shorter, CICU and hospital stays. The 
consistency of this pattern across quadratic and spline models supports the fact that this 
statistical similarity is not simply due to a dichotomized age model. However, the very elderly’s 
statistically similar LOS may relate less to overall “health” and more to discharge logistics. Very 
elderly patients were more often discharged to a rehabilitation or skilled nursing facility rather 
than home, and it is likely that more patients ≥80 years were already established at a facility, 
potentially shortening the time needed to find an open facility bed. The two existing studies with 
similar age-based comparison groups did not report LOS with which to compare.13,14  
Our study population had different lengths of stay than current US CICU literature. Our 
all-age population stayed an average of 10 days in the hospital, compared to 6 days in a recent 
CICU population in Virginia.7 Our very elderly population stayed 3.4 days in the CICU, 
compared to 6 days reported for nonagenarians in Minnesota.12  
 
4.3 Mortality 
Very elderly patients in our study population had similar rates of CICU and hospital 
mortality compared to those <80 years. Chronic comorbidities were not significant factors in our 
age-mortality relationship, however the point estimates for history of CAD, ESRD, CVA and CLD 
indicated increasing odds of CICU and hospital mortality. Female sex was an independent 
predictor of hospital mortality, but not CICU mortality. By contrast, several international studies 
among CICU patients with ACS found no sex-based differences in short15 or long-term 
mortality.13 
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 It is interesting that survivors with CHF stayed significantly fewer days in the hospital, 
yet the point estimate suggested higher odds of mortality associated with CHF. These disparate 
results may be dominated by two CHF subpopulations: those with well-controlled CHF and 
those who are in fulminant failure with cardiogenic shock (the majority of our admission 
diagnoses). Future exploration of the CICU subpopulation with CHF may clarify these results. In 
an all-diagnosis CICU population (57% with ACS) in New York City, heart failure with reduced 
ejection fraction (HFrEF) was an independent mortality predictor, while our combined measure 
of HFrEF and heart failure with preserved ejection fraction (HFpEF) was not.10 
We found a hospital mortality rate (19.4% observed rate and 16.2% predicted rate) that 
is comparable to existing literature. In the US, nonagenarian CICU patients in Minnesota had a 
mortality rate of 15%,12 and French ACS patients ≥80 years had a mortality rate of 18.2%.13 This 
French study is the only known investigation to directly compare mortality rates of those ≥80 
years to younger CICU patients. In contrast to our findings, their very elderly population had a 
significantly higher mortality rate, although this difference was unadjusted and they reported 
similar rates of cardiac death.13 Comparison is difficult due to our population’s dissimilar 
admission diagnoses, covariates, and study setting: there are major differences in biological and 
socioeconomic mortality risk factors between French and US populations. 
We expected that, if anything, quadratic models might bring out a significant age-based 
mortality relationship, which we did not find. Furthermore, the effect of each additional year of 
age does not significantly increase odds of mortality for octogenarians and nonagenarians (nor 
did it for other splined age categories.) Similarly, Italian NSTEMI CICU patients did not have a 
significant increase in odds of mortality per year of age after 75 (OR 1.01, 95% CI 0.95-1.07).15  
Our sample size limited our ability to detect potential differences among many critically ill 
subgroups. However, it is important to consider additional ways of measuring illness severity to 
identify those elderly patients at greatest risk of mortality. Our results suggest that elderly 
patients who are invasively mechanically intubated are at particular risk of mortality, even while 
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controlling for illness severity with SAPS II. Future analysis would benefit from a larger sample 
size to better describe ventilated CICU patients and be adequately powered to detect 
differences in other potential subpopulations at risk. Additional risk stratification scores should 
also be explored, such as the Elders Risk Assessment Score which was found to effectively 
stratify nonagenarians in a CICU based on 3-year mortality.12 Based on existing all-age CICU 
data from the US, many other subpopulations may be at increased risk of mortality independent 
of their illness severity score: an investigation in an all-age New York CICU10 also found that 
invasive mechanical ventilation was an independent mortality predictor, along with cardiac 
arrest, sepsis, acute renal failure, HFrEF, defibrillation, and IABP placement. A Virginian CICU7 
also identified sepsis, acute kidney injury, acute respiratory failure, cardiogenic shock and 
cardiac arrest as independent mortality risk factors. Notably, the Virginian CICU population had 
a much higher prevalence of sepsis (16%) than ours (3.1%).  
 
4.4 Delirium as a Biased, yet Important, Covariate 
Finally, we turn to the issue of delirium, which we did not include as a factor in our main 
models due to the unknown timing of CAM-ICU administration, potentially invalidating the 
measurement tool and preventing us from distinguishing between incident and prevalent 
delirium.18 However, the fact that CAM-ICU positivity at any point during the CICU admission 
was very strongly associated with longer LOS and higher odds of mortality supports its 
importance as an independent outcome predictor for CICU patients of any age, as has been 
previously observed.35,36 Both SAPS II and CAM-ICU score remained significant when included 
together, supporting both indices’ value in the CICU environment across the age spectrum and 
indicating that future studies should include accurately-measured delirium status as a covariate.  
Keeping in mind the potentially biased nature of this covariate, this sensitivity analysis 
supports our conclusion that very elderly patients do not have “worse” outcomes based on age 
alone: our age groups had similar mortality regardless whether delirium was controlled for in the 
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models. As expected, we found that CAM-ICU, as an indicator of ICU delirium, had a stronger 
relationship with CICU mortality rather than hospital mortality.  
 
4.5 Limitations 
 The major limitations of our study include the single-center, retrospective design. We do 
not suspect that our data’s unique transition between ICU models was a major source of bias, 
given its equal distribution between the age cohorts and insignificance as a model covariate. 
Yet, as with all data not collected explicitly for the study’s purpose, unmeasured confounders 
remain possible. Patient identifiers were no longer available in the database, thus we were 
unable to check the accuracy of the information collected except by re-calculating APACHE II 
and SAPS II scores. Several important confounders we were unable to include are: family 
history, smoking status, exercise, independent living status, social support, medications, degree 
of management of chronic conditions prior to admission, and goals of care (including 
resuscitation and intubation preferences).  
 Another major limitation to our data is the lack of long-term and patient-centered 
outcomes. Complication rates, cost of care, loss of independence, and long-term mortality and 
morbidity should be investigated in future studies. There is some evidence in the existing 
literature that very elderly patients may fare worse in patient-centered outcomes. Rosenbaum 
and colleagues observed a decrease in independence at discharge,37 but future investigations 
following functional status longitudinally with a comparison group would be useful. French ACS 
patients aged ≥80 years were less likely to have “zero complications” compared to patients <80 
years (31.2 vs 61.9%).13 Outcomes such as infection, heart failure, atrial flutter, and bleeding 
were included in this study’s definition of “complication,” but it is unclear whether they are 
iatrogenic. Complications after PCI were significantly more likely in NSTEMI patients aged ≥75 
years in Italian ICCUs15 and need for IABP or mechanical ventilation was more likely after PCI in 
Israeli CICU patients aged ≥80 years with STEMI.16 Comparison of complication rates and long 
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term CICU outcomes by age in a US population is an important next step for our understanding 
of how to best care for the very elderly. 
 Finally, there is a degree of self-selection in any population ≥80 years, who represent a 
group of patients who are living longer than the average American. This could be due to a long 
list of unmeasured variables. They may be generally healthier, have had a higher level of 
healthcare access, or had to navigate fewer socioeconomic obstacles throughout their lives. 
Thus, the fact that we were unable to control for many lifestyle and socioeconomic variables 
made our study more likely to find similar outcomes by age. 
 
5. Conclusion 
 This is the first US study to compare clinical characteristics and outcomes of 
octogenarians and nonagenarians to patients aged <80 years in a CICU population, regardless 
of diagnosis. Our findings suggest that age ≥80 years alone is not an independent predictor of 
short-term outcomes (LOS and mortality in the CICU and in the hospital). Patients ≥80 years 
also do not have drastically different cardiovascular risk profiles, reasons for CICU admission, or 
resource utilization rates. Gender, SAPS II score, congestive heart failure, and delirium may be 
more important factors than age when anticipating CICU outcomes. This observational data 
should be substantiated by prospective comparison of additional long-term and patient-centered 
outcomes, in order to provide the best possible care for the very elderly with critical 
cardiovascular illness.  
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Appendix A: Limited Systematic Review on Current Literature About the Very Elderly 
CICU Population 
Introduction 
Rationale 
The American population is aging, and prevalence of cardiovascular disease is 
increasing. Many cardiac conditions are more prevalent in older adults and associated with 
significant morbidity, so the pressure for bed space in Cardiac Intensive Care Units (CICUs) will 
increase.  However, physicians are often tasked with making ICU triage decisions based on 
limited information, and guidelines cite a paucity of evidence surrounding the importance of age 
in decision-making.1 Elderly patients are rejected from ICU beds more often than are younger 
patients.2 Within the geriatric population, octogenarians and nonagenarians may be particularly 
vulnerable to age discrimination, but this cardiac-specific ICU population is poorly characterized.  
The CICU is a surprisingly understudied healthcare setting.3 On initial, limited searches, 
the study author had difficulty finding any studies that specifically compared outcomes of very 
elderly patients to their younger counterparts in a cardiac-specific ICU population. Initial 
searches into Cochrane did not result any currently existing systematic reviews. Thus, a large, 
widely-scoping search of the literature could better uncover any evidence on this important and 
understudied issue.  
Objectives 
The purpose of this review is to determine whether outcomes among very elderly 
patients admitted to the CICU (for any condition) differ from those of younger adults. Although 
our main interest is in adults 80 years and older (compared to those younger), we also included 
studies that examined any alternative dichotomizing point, from age 75 years onward. We 
included this second investigation because of the expected small body of literature addressing 
this topic.   
The two main questions that will be addressed in this study are: 
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Q1: Among patients treated in cardiac-specific intensive care units for any reason, do 
patient outcomes among the very elderly (≥80 years old) differ compared to younger patients, 
as assessed by studies specifically asking this question?  
Q2: Among patients treated in cardiac-specific intensive care units for any reason, do 
very elderly patients (defined as age ≥75 years or any higher cutoff) differ compared to younger 
patients, as assessed by studies with other primary research questions? 
Methods 
Protocol & Search Strategy 
A detailed search protocol and list of search terms is available in Appendix A.2. In brief, 
PubMed and EMBASE were searched for English language articles published at any point in 
time, using search broad search terms to capture any possible relevant studies on this topic. 
ClinicalTrials.gov (and other trial databases) was not searched formally, as most literature on 
this topic is likely to be observational in nature, and limited exploratory searches did not show 
any results. No authors were contacted to inquire about additional studies. The last search was 
performed on April 18, 2018.  
Eligibility Criteria 
One investigator reviewed studies based on a priori eligibility criteria (Table 1).  
Population: Studies enrolling populations treated in a cardiac-specific ICU were eligible 
(this includes medical and surgical ICUs such as CICUs and CTICUs). Because cardiac-specific 
ICUs may be systematically different from medical or surgical ICUs, thus implying a different risk 
profile among very elderly critically ill patients in the CICU, we will focus this systematic review 
only on the CICU population (also commonly called a coronary care unit or CCU), rather than 
any medical, surgical, mixed or unspecified ICUs.  
Exposure: The receipt of care in one of the above cardiac-specific ICUs was considered 
our exposure, which all patients in both comparator groups received.  
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Comparator: For our primary review question focusing on our “ideal” study focusing on 
octo- and nonagenarians specifically, the comparator was patients aged 80 years or above 
compared to younger patients. For our second review question that expanded our acceptable 
studies, a comparator that closely approximated any definition of “very elderly” (any cutoff at 
age 75 years or older) compared to younger patients was included. In addition, we accepted a 
diverse range of “control” groups: which could be all ages under 80 years, or only a subset such 
as 60-80 years.  
Outcome: This systematic review will include studies with any outcome, including short-
term or long-term patient outcomes, cost, or response to certain medical treatments. The point 
of this review is to survey what information we know; thus, inclusion criteria are broad and 
results will be categorized by comparator age cutoff and outcome type. 
Timing: Studies published at any time were eligible, to increase our chances of finding 
relevant studies. 
Setting: Studies published in any country were eligible. Studies without full texts in 
English were excluded due to the difficulty of translating and critically appraising the results.   
Study Design: Studies of any design were eligible. However, case studies with small 
(<10 participants) sample sizes were excluded given the difficulty in interpreting results 
comparing very small groups of patients.   
Table 1: Inclusion and Exclusion Criteria  
 Inclusion Exclusion 
Population All: 
- Patients treated in a 
Cardiac Intensive Care Unit 
(CICU)	
- Can be medical or surgical, 
but must be cardiac-
specific	
All:  
- Non-cardiac-specific ICU 
patients such as medical 
(MICU), surgical (SICU) or 
mixed.	
- Unspecified source 
population	
Exposure All: Receipt of care in CICU  
Comparator Q1: Age ≥80 years compared 
to Age <80. Comparison 
group can have any range of 
age under 80 (i.e. All patients 
Lack of comparator (i.e. 
studies only looking at 
patients over age 80) 
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under 80, or only patients 60-
79, etc.) as primary research 
question comparator. 
 
Q2: Any dichotomous age 
cutoff at age ≥75 years or 
more, as primary or 
secondary research question, 
or as regression term for a 
different research question. 
Outcomes All: Any (examples: 
descriptive statistics, 
mortality, morbidity, 
readmission, length of stay, 
long-term quality of life, 
complications, cost of stay, 
response to a certain 
treatment) 
 
Setting Any country setting  N/A 
Language Full Text Published in English All other languages 
Study Design Any observational study, 
including cohort studies, 
case-series and case-control 
studies 
All other study designs; case 
studies with sample size <10 
 
 
Study Selection 
All abstracts and titles identified in searches were screened by one author against the 
eligibility criteria outlined in Table 1. Full texts of all potentially eligible studies were reviewed 
again using the same criteria.  
Data Collection and Quality Assessment 
 Studies meeting full inclusion criteria were critically appraised using a priori criteria that 
considers risk of bias domains relevant to observational studies including selection bias, 
measurement bias, potential for confounding, and appropriateness of statistical analysis 
(Appendix A.3). In addition, relevant information from each study was abstracted including study 
design, sample size, population characteristics, ICU setting (medical, surgical, or both), 
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comparator (age categories compared), country setting, and outcomes measured. The results 
section then synthesized bias information into levels of risk and broader applicability. 
Summary Measures 
 Evidence from included studies was synthesized qualitatively. 
 
Results 
Study Selection 
 
Figure 1: Flow Diagram of Study Selection 
  
	 40	
Study Characteristics 
Our search returned 3743 possible results, and after abstract and full-text screening we found 2 
studies4,5 addressing Q1 and 7 studies6–12 addressing Q2 (see Figure 1, above). All of the 9 
included studies were set outside the United States. Most were from European countries, 2 
were from Israel and 1 was from Brazil. The majority were prospective cohort studies4,5,9–12 while 
the others were retrospective cohort studies6–8. Outcomes from 2 studies were collected after 
20105,11. Only one study12 looked at all CICU patients regardless of diagnosis—the other 8 
focused on the subpopulation of CICU patients with ACS-related diagnoses (including STEMI, 
NSTEMI, UA, or all ACS diagnoses). 
In the 2 studies addressing Q1 (from Brazil5 and France4), both used relatively recent data 
(2011-20165 and 2006-20074) on subpopulation of patients admitted to the CICU specifically for 
ACS (Acute Coronary Syndrome). Their primary research questions differed from each other 
and focused on predictors of 6-month outcomes4 or the GRACE score as a predictor of in-
hospital mortality5. Both had comparable admission criteria in the sense that both looked at ACS 
patients in the CICU, but one study provided more specific ACS criteria, including numeric 
biomarker thresholds (see Table 1a).5 
The 7 studies addressing Q2 included a range of age comparisons: 3 compared the ≥80 
group with 2-3 younger age groups,6,8,12 while 4 used ≥75 as their elderly age group. Age-based 
results were incorporated as a regression covariate in 3 studies6,7,9, and one study analyzed 
data as part of descriptive statistics12, as a secondary analysis8, and as a primary analysis10 
(see Table 2a). 
Risk of Bias of Individual Studies  
 Tables 2a and 2b summarize the potential bias across included studies. Of the two 
studies included for Q1, one was of medium risk of bias and medium applicability, and one was 
of low risk of bias and high applicability. Common sources of bias included unexplained 
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acronyms, which limited result interpretability. One study was limited in applicability because it 
was a single center, international study performed over 10 years ago. 
 There was a wide range of quality among studies addressing Q2. Zobel et al.12 has the 
lowest risk of bias, represents the only study conducted among all-cause CICU patients, and is 
a recent study, but unfortunately has a limited amount of age-related information. The study with 
the most recent data, Topaz et al.11, unfortunately has high risk of bias and low applicability.  
Synthesis of Results  
 Results of included studies are summarized in Tables 3a and 3b. Among CICU patients 
admitted with suspected ACS, patients aged 80 years or over had proportionately more women, 
as do patients aged 75 years or older. The one study examining all-cause CICU patients found 
no difference in gender distribution based on age.  
 Among Q1 studies4,5, there were mixed results on whether diabetes, NSTEMI, or rates of 
PCI were associated with age. Both studies found that patients aged ≥80 years were more likely 
to have multi-vessel disease. The one study to investigate mortality outcomes4 found that 
patients aged ≥80 years were more likely to die in the hospital, but rates of cardiac in-hospital 
death and 6-month mortality were not different based on age. 
 Among Q2 studies that included an ≥80 very elderly group, there were trends toward 
increased 2-year mortality in the pre-drug eluting stent (DES) era (pre-2003)6,7 and no difference 
in hazard ratio of 1-year mortality in the post-DES era.8 Among patients aged ≥80 years, men 
were more likely to die within a year, while there was no difference in gender-based mortality for 
patients <70 years.  
 Among Q2 studies defining very elderly as aged ≥75 years, in the pre-stent era9 older 
patients were more likely to receive thrombolytics and less likely to die in the hospital compared 
to younger patients who also received thrombolytics. NSTEMI patients age ≥75 years had a 
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trend (significance unknown) of higher rates of 30-day mortality and complications.10 STEMI 
patients ≥7511 years had higher mortality after average follow-up of 3.4 years. Isolating the 
cardiogenic shock population negated age-based differences in mortality.  
Table 1a: Characteristics of Studies Addressing Q1 
Study & 
Publication 
Date 
 
Location 
 
Design 
 
Date of Data 
Collection 
Main Study Question Age 
Comparison 
& 
Role in Study 
(primary analysis; 
secondary 
analysis; or 
regression item) 
Recruitment Source 
& 
Main Inclusion/Exclusion 
Criteria 
 
 
Austruy et al. 
2008 
 
France 
 
Prospective 
Cohort 
 
May 2006-
January 2007 
Q1 
 
What are the 
predictive factors of 
poor outcome at 6 
months among 
patients ≥80 admitted 
to CICU with ACS? 
 
≥80 years 
vs 
<80 years 
 
Primary Analysis 
 
Rangueil University Hospital CICU in 
Tolouse 
 
Inclusion: 
Admitted 5/2006-1/2007 
Admitted with ACS diagnosis 
(ACS criteria: elevated troponin or ST 
changes on EKG) 
 
 
Cerqueira Jr. 
et al, 2018 
 
Brazil 
 
Prospective 
Cohort 
 
September 
2011-August 
2016 
Q1 
 
Is GRACE score an 
accurate predictor of 
in-hospital mortality 
among ≥80 
population with ACS? 
≥80 years 
vs 
<80 years 
 
Primary Analysis 
 
One tertiary hospital’s ICCU  
 
Inclusion: 
Admission during study period 
Suspected ACS (UA or MI)  
(ACS Criteria: 1+ of 
Positive myocardial necrosis marker 
(Trop T or Trop I, # thresholds given) 
Ischemic EKG changes (T inversion or 
ST changes, # thresholds given) 
Prior CAD (history of MI with Q wave or 
prior angiography with obstruction 
≥70%) 
Abbreviations: 
ACS = acute coronary syndrome 
AMI = acute myocardial infarction 
CAD = coronary artery disease 
CCU = coronary care unit 
CICU = cardiac intensive care unit 
ICCU = intensive coronary care unit 
MI = Myocardial Infarction 
NSTEMI = non-ST Segment Elevation MI 
UA = unstable angina 
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Table 1b: Characteristics of Studies Addressing Q2 
Study & 
Publication 
Date 
 
Location 
 
Design 
 
Date of Data 
Collection 
 
Main Study 
Question 
Age 
Comparison 
& 
Role in Study 
(primary analysis; 
secondary 
analysis; or 
regression item) 
Recruitment Source 
& 
Main Inclusion/Exclusion 
Criteria 
 
 
Abrahamsson 
et al. 1998 
 
Sweden 
 
Retrospective 
Cohort 
 
1984-1991 
Did 2-year mortality 
after MI decrease 
over the time period 
of introduction of 
beta-blockers, ASA 
& thrombolytics?  
≥80 years 
vs 
70-80 years 
vs 
≤70 years 
 
Regression Item 
Citizens of Göteburg admitted to Östra 
Hospital CCU  
 
Inclusion:  
Admitted 1984-1991 
Admitted with MI diagnosis 
(MI criteria: 2+ of 
chest pain, shock, syncope or pulmonary 
edema; AST, CK or CKMB above defined 
threshold; Q waves or serial ST-T 
changes on EKG) 
Abrahamsson 
et al. 2000 
 
Sweden 
 
Retrospective 
Cohort 
 
1988-1997 
Did 2-year mortality 
after UA or non-Q-
wave MI decrease 
over the time period 
of introduction of 
beta-blockers, ASA 
& thrombolytics? 
 
≥75 years 
vs 
65-75 years 
vs 
<65 years 
 
Regression Item 
Citizens of Göteburg admitted to Östra 
Hospital CCU  
 
Inclusion: 
Admitted 1988-1997 
Admitted with UA or non-Q-wave MI 
diagnosis 
(UA Criteria: 1+ of 
“clear worsening” of prior stable angina; 
chest pain + transient ST change on 
EKG; enzyme elevation below MI 
threshold. 
 
Non-Q-wave MI Criteria:  
AST, CK or CK-MB above defined 
threshold 
& 1+ of: 
Chest pain, shock, syncope or pulmonary 
edema; serial ST-T changes without Q 
waves on EKG.) 
 
Exclusion:  
readmission cases 
Alfredsson et 
al. 2007 
 
Sweden 
 
Retrospective 
Cohort 
 
1998-2002 
Are there gender 
differences in 
demographics, 
management & 
outcome in ICCU 
(intensive coronary 
care unit) population 
with NSTEMI? 
≥80 years 
vs 
70-89 years 
Vs 
60-69 years 
vs 
≤59 years 
 
Secondary 
Analysis 
Swedish Heart Intensive Care 
Admissions (RIKS-HIA) registry of all 
ICCU patients admitted to participating 
hospitals in Sweden (increased from 
19/78 hospitals in 1997 to 70/78 
hospitals in 2002) 
 
Inclusion: 
Admitted 1998-2002 
Discharged with NSTEMI or UA diagnosis 
(WHO criteria for MI and UA 
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 & Biochemical criteria by ESC/ACC 
guidelines 
 
Behar et al. 
1991 
 
Israel 
 
Prospective 
Cohort 
 
January 1990 
Incidence of 
thrombolytic therapy 
& reasons for 
ineligibility among 
AMI patients 
≥75 years 
vs 
<75 years 
 
Regression item 
 
18 of the 23 CCUs in Israel 
 
Inclusion: 
Hospitalized during January 1990 
Diagnosis of AMI 
(AMI Criteria: 
typical chest pain, “characteristic EKG 
changes” and “high levels of” CK-MB, 
glutamic oxalotransaminase, LDH) 
 
 
De Servi et al. 
2003 
 
Italy 
 
Prospective 
Cohort 
 
May and June 
2002 
What is the current 
care of NSTEMI 
patients over 75 
(use of antiplatelets 
& aggressive or 
conservative 
strategy)? 
≥75 years 
vs 
<75 years 
 
Primary Analysis 
 
76 CCUs in 7 regions of North and 
Central Italy, selected to represent 
balance of 38 hospitals with a CCU but 
no catheterization lab & 38 hospitals 
with a CCU and a catheterization lab. 
 
Inclusion: 
Admitted to centers during 2-month study 
period. 
Admission diagnosis of NSTEMI 
(NSTEMI Criteria 1+ of: 
new ST depression 
T wave inversion 
Transient ST elevation 
Elevated cardiac enzymes above normal 
limit for each hospital’s laboratory 
(Troponin T or I) 
Known CAD (documented history of MI or 
revascularization 
AND 
CK or CK-MB elevation 2x normal 
reference range after PCI or 5x after 
CABG; OR new Q waves on EKG in 2 
contiguous leads. 
 
Exclusion: 
Persistent ST elevation >20min 
Received thrombolytics or PCI within 24 
hours 
Admission diagnosis of noncardiac chest 
pain 
Were transferred for planned PCI 
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Topaz et al. 
2017 
 
Israel 
 
Prospective 
Cohort 
 
January 2008-
December 
2014 
What is the 
complication and 
mortality rate of 
STEMI patients 
aged ≥75 versus 
<75? 
≥75 years 
vs. 
<75 years 
 
Primary Analysis 
Tel Aviv Medical Center’s 
Catheterization Lab vs. CICU (unclear) 
 
Inclusion: 
Received PCI (unclear) 
Treated in CICU 
Diagnosis of STEMI  
(STEMI criteria: “history of typical chest 
pain, diagnostic EKG changes, serial 
elevation of cardiac biomarkers” no 
specifics given.) 
 
Zobel et al. 
2012 
 
Germany 
 
Pros 
 
January 2008-
December 
2009 
What is the mortality 
and morbidity of an 
all-cause CICU 
population? 
≥80 years 
vs. 
30-80 years 
vs. 
<30 years 
 
Descriptive 
Analysis Sub-
population  
 
6-bed CICU at Heart Centre of the 
University of Cologne (from 
description, unclear but it seems this 
is a CICU within a general ICU) 
 
Inclusion: 
All patients admitted to CICU within study 
period 
 
 
Table 2a: Risk of Bias in Studies Addressing Q1 
Study & Date 
 
Risk of Bias 
(Internal 
Validity) 
 
Overall 
Applicability 
(External 
Validity) 
Comments on Bias Comments on Applicability Overall Significance to 
purposes of this Review 
Austruy et al. 
2008 
 
Bias: medium 
 
Applicability: 
medium 
Table 1 unspecified at 
times: “hereditary” 
cardiovascular disease, 
“smoking (absence)” which 
I assume means non-
smoking? Abbreviations 
are not explained—AOLL? 
PM? CBS? 
 
Other results also not 
(-) 
>10 years ago 
 
single-center 
 
international (different risk 
profile) 
 
small N 
 
Despite medium 
applicability, high 
significance, because it is 
the only thorough, 
prospectively collected 
description of 
octogenarians in a CICU 
population, within 15 years 
ago. However, limited to 
those admitted with ACS. 
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explained—the timing of 
the 6 month outcomes 
unclear if includes in-
hospital events as well. 
 
Although not well 
explained, many 
confounders were 
considered including 
various measures of 
functional status—when 
determining multivariate 
predictors of 6-month 
mortality. 
(+) 
within 15 years 
therapy more comparable 
to modern treatment than 
other studies in this list—
angiography, etc. used 
 
 
 
Useful inclusion of patient-
centered measures: IADLs, 
independence, etc.—but no 
6-month data on these 
measures. 
Cerqueira Jr. 
et al, 2018 
 
Bias: low 
 
Applicability: 
high 
Well defined inclusion 
criteria 
 
Clearly defined what data 
used to calculate GRACE 
score 
 
Unexplained items in 
Table 1: “Non-ST ACS” 
and “Non-ST” with 
different numbers 
 
Statistical tests used were 
defined and mostly 
replicable. 
 
Unclear if only applied to 
patients who came to 
CICU through the ED, or 
through other avenues as 
well. 
 
 
(-) 
single center 
 
international 
 
Only ACS patients 
 
(+) 
very recent, using modern 
standards of diagnosis and 
definition, with modern 
treatment modalities  
 
 
High significance. GRACE 
was developed in a 
younger population, thus 
questioning validity of risk 
scores in octogenarians is 
important. 
 
Again, significance is 
limited only to 
octogenarians in CICU with 
ACS, not the overall all-
cause CICU population 
IABP = intra-aortic balloon pump 
 
Table 2b: Risk of Bias in Studies Addressing Q2 
Study & Date 
 
Risk of Bias 
(Internal 
Validity) 
 
Overall 
Applicability 
(External 
Validity) 
Comments on Bias Comments on Applicability Overall Significance to 
purposes of this Review 
Abrahamsson 
et al. 1998 
 
Bias: high 
 
Applicability: 
RR calculations not 
controlled for other 
variables. 
 
MI criteria appropriate for 
time. 
(-) 
>30 years ago 
 
Single-center 
 
International 
Low significance due to low 
applicability to modern 
times (treatment options 
have changed with 
introduction of PCI; 
definition of MI has 
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low  
Mortality data from 
national registry, may miss 
patients who moved. 
 
Unclear handling of 
readmission cases 
 
Very little explanation of 
statistical analysis. 
changed with introduction 
of more sensitive 
biomarkers) 
Abrahamsson 
et al. 2000 
 
Bias: high 
 
Applicability: 
low 
Uses standardized 
database collected for 
every consecutive CICU 
patient. 
 
Only 3203/3918 patients 
were followed for 2 years 
 
Standardized criteria for 
UA and non-Q MI 
 
Mortality data from 
national registry, may miss 
patients who moved. 
 
Age missing in 15 cases 
but no mention of how 
handled 
 
Very little explanation of 
statistical methods. 
(-) 
>20 years ago 
 
Single-center 
 
International 
 
Low significance due to 
significant changes in 
treatment and definition of 
MI (biomarkers, atypical 
symptoms) 
 
 
Alfredsson et 
al. 2007 
 
Bias: medium 
 
Applicability: 
medium 
Biochemical EHA criteria 
revised during study 
period with change in 
guidelines. 
 
Authors estimate that 95% 
of Sweden’s ICCU 
admissions during study 
period were included in 
2002. 
 
Database collection items 
standardized across sites 
and quality monitored by 
external source’s patient 
record comparison (kappa 
94%) 
 
Mortality data from 
Swedish National Death 
Registry—may miss 
patients who move. 
 
Age-adjusted Cox 
Regression included 
(-) 
>15 years ago 
 
International 
 
(+) 
Comprehensive database 
encompassing entire 
country 
 
Multi-center 
 
 
 
 
 
Medium significance given 
comprehensiveness of 
database, yet data >15 
years old and in different 
country that has different 
risk profile than many other 
nations. 
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appropriate control 
variables (demographics, 
smoking, prior MI-related 
procedures, comorbidities, 
home medications, EKG 
changes and biomarkers. 
Behar et al 
1991 
 
Bias: high 
 
Applicability: 
low 
No central review of AMI 
diagnoses. 
 
There were no uniform 
guidelines for thrombolytic 
therapy at the time—those 
who received vs did not 
may be systematically 
different. 
 
“insignificant” p values not 
reported, simply declared 
insignificant without 
number. 
 
Age-based exclusion 
depended on each 
center’s exclusion criteria. 
4/18 centers considered 
age>75 a criterion. 
 
“thrombolytic therapy” 
never precisely defined 
>15 years ago 
 
single international country 
 
relatively small N 
 
no angiography used, only 
medical therapy. Very 
different from modern MI 
therapy. 
Low. Therapy and setting 
vastly different, and results 
themselves have high risk 
of bias.  
De Servi et 
al. 2003 
 
Bias: medium 
 
Applicability: 
medium 
Prospective 
 
Standardized form used to 
collect information 
 
Standardized definition of 
MI across centers. 
 
No patients lost to follow 
up 
 
Number value of “not 
significant” p values not 
reported 
 
Troponins missing in 325 
patients; TIMI score 
missing in 55 
 
Included appropriate 
confounding variables in 
multivariate model—but 
they may not have 
controlled for study center 
(PCI v non-PCI capable). 
Unclear. 
(-)  
>15 years ago--PCI and 
NSTEMI technology has 
advanced since 2003 
 
diagnosis has changed—
criteria was set with CK-MB 
here. 
 
International 
 
(+) 
multi center 
 
 
 
Medium, because it is one 
of few prospectively 
collected studies focusing 
on age as primary 
question—but is >15 years 
old and cutoff includes 
those 75 to 79. 
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Topaz et al. 
2017 
 
Bias: high 
 
Applicability: 
low 
Inclusion criteria unclear—
are these all patients in 
CICU or only those who 
received angiography? 
 
No explanation of which 
variables were controlled 
for in multivariate analysis. 
 
No description of follow 
up—how outcomes were 
followed of obtained. 
 
No specification of what 
“long term mortality” 
meant. 
(-) 
Criteria used to define 
many conditions is different 
from European and US 
standards: 
 
PCI given if symptoms 
occurred within 12 hours, or 
persisted for 12-24 hours 
after admission. 
 
Cardiogenic shock defined 
as need for IABP or 
mechanical ventilation. 
Low, simply because 
patient population vaguely 
defined, study methods not 
well described in general 
and treatment protocols 
very different from most 
other countries.  
Zobel et al. 
2011 
 
Bias: low 
 
Applicability: 
medium 
“new” CICU may introduce 
unknown confounders 
from personnel getting 
used to unit over time 
during the 2-year period. 
 
Diagnostic standards not 
specified (STEMI, etc.) 
 
 
(-) 
single-center 
international 
 
(+) 
decent sample size 
 
Relatively recent study 
reflecting modern CICU 
care 
 
 
 
 
Medium significance. 
Important because it’s the 
only other known study 
looking at all cause 
consecutive CICU patients, 
not just an ACS-related 
population. 
 
Less important because 
amount of age-based 
information is very limited. 
 
 
Table 3a: Results of Studies Addressing Q1  
Study & Date 
 
N: Mean Age 
(SD) 
Of 
Comparator 
Groups  
Age-based 
Outcome(s) 
examined 
& 
Length of 
Follow-up 
 
Subgroups 
Examined? 
Demographics & 
Baseline 
Characteristics 
Of Age-based 
Comparator 
Groups 
Age-Relevant Results 
Austruy et al. 
2008 
 
≥80:  
132: 84.0 
(3.1) 
 
<80  
127: 57.8 
(13.6) 
1. Admission 
clinical 
details 
2. Treatment
s received 
3. Hospital 
Outcomes 
4. Discharge 
treatment 
5. Treatment 
at 6 
months. 
Gender:  
≥80:  
64 (48.8%) 
women 
<80: 
36 (38.1%) women 
p=<0.0001 
 
BMI: 
≥80:  
25.4 (4.2)  
<80 
1.  
≥80 group were more likely to have (p<0.05): 
heart failure on admission, but less likely to 
have angina. ≥80 group had significantly higher 
HR* and SBP on admission. 
 
On EKG, ≥80 group were more likely to have 
(p<0.05): AVB. There was no difference in any 
STEMI, anterior STEMI, LBBB, Q waves, or 
atrial flutter.  
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6. Outcomes 
at 6 
months 
7. Total 
Mortality 
8. Factors 
predicting 
6-month 
mortality in 
≥80 group 
 
6-month follow 
up 
 
No subgroups 
BMI 26.9 (4.8) 
P=0.03 
 
Accommodation: 
≥80:  
12 (10.4%) in 
institution 
<80: -- 
 
Independence 
From 3rd parties in 
daily life: 
≥80:  
57 (49.6%) 
<80: -- 
 
Eligible for 
independence 
allowance: 
24 (22.2%) 
<80: -- 
 
IADL Score: 
≥80:  
0=10(9%) 
1=14 (12.6%) 
2=14(12.6%) 
3=37(33.3%) 
4=36(32.4%) 
 
Past Medical 
History: 
≥80 group were 
more likely to have 
(p<0.05) history of: 
HTN, ischemic 
heart disease, left 
valve disease, 
vascular surgery, 
stroke, dementia, 
and fall within last 3 
months.  
 
≥80 group were 
less likely to have 
(p<0.05) history of: 
hyperlipidemia, 
hereditary 
cardiovascular 
disease risk factors 
or active smoking. 
 
≥80 group had significantly higher: Hgb, BG and 
Cr, lower Cr clearance, and were more likely to 
have elevated Troponins. There were no 
differences in Na and blood protein. 
 
On x-ray ≥80 group were more likely to have: 
cardiomegaly and LHF, while patients <80 were 
more likely to have a normal chest x-ray. 
 
On ultrasound, ≥80 group had significantly 
lower LVEF (45% vs 55%) and more valve 
disease.  
 
2. 
Prior to admission, ≥80 group were less likely to 
receive antiplatelets, heparin or fibrinolytics, but 
more likely to get diuretics and anti-G6IIb/IIIa 
agents. There was no difference in time to 
fibrinolysis but a trend. 
 
In the hospital, ≥80 group was less likely to 
receive coronary angiography or “active stents” 
(DES?), but received more stents (2 v 1) and 
were more likely to have triple artery 
involvement or >50% stenosis of LM. 
 
There was no difference in management 
approach (medical, angiography, CBS). 
 
3.  
≥80 group were less likely to have 0 
complications (31.2 vs 61.9%) and more likely 
to experience in-hospital ischemia, heart failure, 
atrial flutter, arrhythmia, acute kidney failure, 
bleeding, infection, agitation, and receive a 
pacemaker. 
 
In the hospital, 24 (18.2% of ≥80 group died) vs 
4 (3.2%) of <80 group. (p<0.0001) 
 
Among the deaths, there was no difference in 
proportion of cardiac death.  
 
 4.  
≥80 group was discharged on significantly more 
drugs, and were more likely to be discharged 
with an anticoagulant, diuretic, nitrate, 
amiodarone, PPI, or benzodiazepine. They were 
less likely to be discharged on Clopidogrel or a 
statin. 
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There was no 
difference (p>0.05) 
in history of: 
diabetes, stents, 
CABG, “AOLL”, 
heart failure, 
stroke, “PM”, 
depression, severe 
bleeding, COPD, or 
cancer. 
 
 
5.  
at 6 months, ≥80 group was less likely to be on 
a beta blocker or ACEi, and more likely to be on 
a diuretic, nitrate, CCB, amiodarone, and benzo.  
 
6.  
at 6 months, 13 (12%) of the ≥80 group had 
died vs. 9 (7.4%) of the <80 group (p=0.24) 
 
By 6 months, rates of:  
Recurrent ACS 17.9% (≥80) v 13.2% (<80) 
p=0.33 
New revascularization 7.6% v 5.8% p=0.58 
Stroke 0.8% v 2.8% p=0.34 
Heart Failure 37.7% v 12.4% p=<0.0001 
 
7. 
Overall, 37 (28%) of ≥80 group died in hospital 
or within 6 months vs 13 (10.6%) of <80 group. 
 
8. 
Univariate predictors of 6-month mortality: 
History of heart failure (p 0.01) 
Cardiovascular history (p 0.03) 
Left valve disease (<0.01) 
IADL <2 (0.05) 
Angina (<0.0001) 
Atrioventricular block Grade 2+ (0.02) 
Atrial fibrillation/flutter (0.05) 
Current heart failure (<0.01) 
No revascularization (<0.01) 
No anticoagulants at discharge (0.01) 
No statins on discharge (<0.01) 
No ACEi on discharge (0.02) 
No Benzodiazepine on discharge (0.02) 
Lower SBP at admission (<0.0001) 
Higher HR at admission (<0.01) 
Lower LVEF in hospital (<0.0001) 
 
 
Insignificant predictors: 
Gender; ACS (STEMI or NSTEMI); beta 
blockers on discharge; diuretics on discharge; 
increasing age above 80; weight; BG; Cr 
clearance at admission or discharge 
 
Multivariate predictors: 
CV History: OR 5.83(1.79-19.0) 
Atypical Symptoms vs Angina:  
6.73(2.00-22.6) 
SBP<101mmHg: 5.62(1.5-21.1) 
HR>99: 0.99-11.0 
Anterior STEMI vs other ACS: 5.10 (1.48-17.6) 
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Cerqueira et 
al. 2018 
 
≥80:  
173: 85 (3.5) 
 
<80:  
821: 61 (11) 
1. Admission 
Vitals, 
Diagnoses
, and Test 
Results 
2. Interventio
ns 
3. Accuracy 
and ROC 
Curves of 
GRACE 
score for 
in-hospital 
mortality 
prediction 
4. In-hospital 
mortality 
by GRACE 
tertile 
 
In-hospital 
follow up 
 
Subgrouped 
by GRACE 
Score tertile 
Gender:  
≥80:  
82 (47%) men 
 
<80: 
487 (59%) men  
 
p=<0.004 
 
Past Medical 
History: 
Diabetes 
≥80: 60 (35%)  
<80: 300 (37%) 
p=0.61 
 
 
 
1. 
GRACE Score at admission: 
≥80: 162(34) 
<80: 115(35) 
p = <0.001 
 
“Non-ST elevation ACS” (unclear if history or on 
admission) 
≥80: 23 (13%)  
<80: 821: 61 (11%) 
p=0.001 
 
“Non-ST elevation” (unclear difference from 
above) 
≥80: 55 (32%)  
<80: 308 (37.5) 
p=0.16 
 
Difference in degree of Killip Classification Heart 
Failure: 
p<0.0001 
Class I: 73% ≥80 vs 88% <80 
Class II: 12% ≥80 vs 6% <80 
Class III: 13% ≥80 vs 5% <80 
Class IV: 1.2% ≥80 vs 0.9% <80 
 
Similar SBP: 151(32) vs 155(30) 
P = 0.09 
 
Similar HR: 80(17) vs 80(18) 
P = 0.52 
 
Similar Cr: 1.1(0.5) vs 1.1(0.9) 
P = 0.67 
 
Lower Hgb in ≥80 (13(1.8)) vs <80 (14(1.9)) p 
<0.001 
 
2. 
≥80 less likely to receive 
Revascularization Surgery (2% vs 11%) 
P <0.001 
 
No statistical difference in rate of  
PCI (39% vs 45%) p=0.13 
 
Among those with PCI, 
≥80 were more likely to have triple-vessel or left 
main disease  
(30% vs 18%) p = <0.001 
 
3. 
GRACE’s Statistic-C of predicting death: similar 
by age group. 
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Overall Sample: 0.87 (0.82-0.92) 
≥80: 0.86 (0.78-0.93) 
<80: 0.83 (0.75-0.91) 
p = 0.69 
 
Cutoff score with best performance: 
≥80: 184. Sensitivity 77%, specificity 87%. 
<80: 134. Sensitivity 83%, specificity 76%. 
 
4. 
By GRACE tertile, there was appropriate 
predicted vs actual hospital death in all but the 
highest tertile. In both groups, GRACE 
underestimated hospital mortality. 
 
  
 
 
 
 
Abbreviations: 
-- = no information provided 
ACEi = ACE inhibitor 
AOLL = undefined and unknown 
AVB = atrioventricular block 
BG = blood glucose 
CABG = coronary artery bypass graft 
Cr = creatinine 
CBS = undefined in paper. I assume coronary bypass surgery. 
CCB = calcium channel blocker 
DES = drug eluting stent 
GRACE = Hospital death prediction score for ACS patients 
HF = heart failure 
Hgb = Hemoglobin 
HR = hazard ratio 
HR* = heart rate 
IADL = independent activities of daily living 
LHF = left heart failure 
LMWH = low molecular weight heparin 
LVEF = Left ventricular ejection fraction 
M = Men 
Na = blood sodium 
NSTEMI = non-ST-segment-elevation myocardial infarction 
PCI = percutaneous coronary intervention 
PM = undefined and unknown 
PPI = proton pump inhibitor 
SBP = systolic blood pressure 
STEMI = ST-segment-elevation myocardial infarction 
W = Women 
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Table 3b: Results of Studies Addressing Q2 
Study & Date 
 
N: Mean Age 
(SD) 
Of 
Comparator 
Groups  
Age-based 
Outcome(s) 
examined 
& 
Length of 
Follow-up 
 
Subgroups 
Examined? 
Demographics & 
Baseline 
Characteristics 
Of Age-based 
Comparator 
Groups 
Age-Relevant Results 
Abrahamsson 
et al. 1998 
 
≥80:  
552: -- (--) 
 
70-80:  
1464: -- (--) 
 
<70:  
1773: -- (--) 
 
1. Absolute # 
& 
proportion 
of MI cases 
by year 
2. Absolute # 
& 
proportion 
of MI cases 
with 2-year 
mortality 
by year 
3. Relative 
Risk of 2-
year MI 
Mortality 
per 
chronologi
c year 
1984-1991 
 
2-year follow 
up 
 
No subgroups 
-- 1. No statistical tests, but # of cases for all age 
groups increased, peaked at 1988 and then 
decreased. 
≥80 population had lowest % of MI cases every 
year. 
 
2. ≥80 group had largest % mortality every year, 
which ranged from 62% (1985) to 38% (1991) 
 
3. RR(95% CI) per year: 
≥80: 0.91 (0.84-0.98) 
70-80: 0.87 (0.83-0.91) 
≤70: 0.86 (0.82-0.91) 
Abrahamsson 
et al. 2000 
 
≥75:  
1066: -- (--) 
 
65-75:  
1063: -- (--) 
 
<65:  
1059: -- (--) 
1. Absolute # 
& 
proportion 
of MI 
cases by 
year 
2. Absolute # 
& 
proportion 
of MI cases 
with 2-year 
mortality 
by year 
3. Relative 
Risk of 2-
year MI 
Mortality 
per 
chronologi
c year 
 
-- 1. No statistical tests, but # of cases for all age 
groups had no clear pattern of increase or 
decrease between 1988 and 1995. 
Age distribution of MI cases was roughly 1/3 in 
each category per year equally. 
 
2. No statistical test, but % mortality for all age 
groups decreased over time. ≥75 group had 
largest % mortality every year, which ranged 
from 47% (1988) to 29% (1995). The most 
recent data set: 29%, 17% and 6.8% of the ≥75, 
65-75, and <65 groups died within 2 years. 
 
3. RR(95% CI) per year: 
≥75: 0.92 (0.87-0.97) 
70-80: 0.94 (0.88-0.998) 
≤70: 0.87 (0.90-0.97) 
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2-year follow 
up 
 
No subgroups 
Alfredsson et 
al. 2007 
 
≥80:  
13132: -- (--) 
 
70-79:  
18155: -- (--) 
 
60-69:  
11980: -- (--) 
 
<60: 
10514: -- (--) 
 
1. Gender-
based 
difference
s in 
procedur
es & 
medicatio
ns within 
individual 
age strata 
(not 
between) 
2. Adjusted 
1-year 
mortality, 
by sex, 
within 
individual 
age 
strata, by 
Cox 
regressio
n 
 
1-year follow 
up 
 
Subgrouped 
by Gender 
N by Sex 
 
≥80: 
M= 6585 
W= 6547 
 
70-79: 
M=11216 
W= 6939 
 
60-69: 
M=8326 
W=3654 
 
<60: 
M=7893 
W=2621 
 
1.  
≥80: 
at p=0.05 level, men were more likely to receive 
GPIIb/IIIa inhibitors, stress tests, 
echocardiography, angiography, CABG, and 
ASA/thrombotics. Genders were comparable in 
receipt of heparin, nitroglycerin, PCI, ACEi beta 
blockers and lipid lowering agents. 
 
70-79: 
Men were more likely to get stress tests, 
angiography, CABG, and significantly less likely 
to get lipid-lowering agents. 
 
60-69: 
Men were more likely to get G6IIb/IIIa inhibitors, 
stress tests, CABG, ACEi. Women were more 
likely to get lipid-lowering drugs. 
 
<60: 
Men were more likely to get echocardiography, 
PCI, CABG, ACEi, beta blockers and lipid-
lowering drugs. 
 
2. In the 70-79 & ≥80 cohorts, men had 
significantly higher probability of 1-year 
mortality. In the <60 and 60-69 cohorts, there 
was no gender difference in mortality 
probability. 
 
Based on this systematic review’s interpretation 
of HR confidence intervals (no formal statistical 
test provided), there is no significant difference 
of hazard of 1-year mortality between age 
strata: 
 
HR (95% CI) at 1 year: 
≥80: 1.13 (1.05-1.20) 
70-79:  1.14 (1.05-1.23) 
60-69: 0.99 (0.85-1.16) 
<60: 1.12 (0.85-1.47) 
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Behar et al. 
1991 
 
≥75:  
353: -- (--) 
 
<75:  
60: -- (--) 
1. N and % 
receiving 
thromboly
tics 
2. Age-based 
exclusion 
from 
thromboly
tics 
3. N and % 
of in-
hospital 
mortality 
 
In-hospital 
follow-up 
 
Subgrouped 
by Receipt of 
Thrombolytic 
Therapy 
-- 1.  
≥75: 134 (38%) received thrombolytics 
<75: 11 (18%) received thrombolytics 
p = <0.0005 
 
2.  
Of the reasons for thrombolytic exclusion, age 
>75 accounted for 16 of 268 patients excluded 
(6%) 
 
3.  
≥75 with thrombolytics: 7 (5%) died 
<75 with thrombolytics: 1 (9%) died 
p = <0.0001 
 
≥75 without thrombolytics: 36 (17%) died 
<75 without thrombolytics: 16 (33%) died 
p = “insignificant 
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De Servi et 
al. 2003 
 
≥75: 
564: 
80.2(4.3) 
 
<75: 
1017: 
61.7(9.2) 
1. Symptom
s at 
admissio
n 
2. Test 
results 
3. Drugs in 
CCU 
received 
4. Treatmen
t: 
Aggressi
ve 
(arteriogr
aphy 
within 96 
hours of 
admissio
n) or 
Conserva
tive 
5. In-
hospital 
outcome
s 
6. 30-day 
outcome
s 
7. Predictor
s of 30-
day 
composit
e 
outcome 
(death, MI 
or stroke) 
 
30-day follow 
up 
Gender: 
≥75: 
237(42%) female 
<75: 
277(22.2%) 
female 
p=<0.001 
 
Past Medical 
History: 
≥75 were more 
likely (p<0.01) to 
have history of: 
hypertension, 
smoking, MI, 
angina, and prior 
aspirin use. 
 
No difference in 
history of: diabetes, 
hyperlipidemia, 
obesity, CABG, PCI 
1.  
No difference in likelihood of: 
Killip class III or IV of HF in NSTEMI 
≥75 28(5.1%)  
<75 44 (4.3%) 
p = “not significant” 
 
Chest pain within 30 min 
≥75 348 (61.7%) 
<75 607 (59.7%) 
 
Chest pain within 24 hours 
≥75 343 (60.8%) 
<75 623 (61.3%) 
 
2.  
≥75 more likely to have ST depression (53.7% v 
42.8%, p <0.001) or raised Troponin (66.3% v 
59.5%, p 0.05) 
 
No difference in transient ST elevation, inverse 
T waves, or presence of Q waves at admission. 
 
TIMI risk score: 
No difference in scores 0-2 (7.3% vs 22.6%), 3-
4 (52.8% vs 51.5%) but ≥75 more likely to have 
TIMI 5+ (36.7% vs 22.2%) 
 
Among those with angiography: 
# of vessels affected significantly higher in ≥75 
group (p<0.0001). 
0,1,2,3-vessel CAD %s: 
≥75: 10, 21, 30, 39 
<75: 13.5, 36, 25, 25.5 
 
EF was significantly more likely to be <50% in 
≥75 group (43% were <50 vs 30%, p<0,01 
 
3.  
≥75 more likely to receive in CCU: LMWH 
(64.5% v 54%, p<0.001); ACEi (60.8% v 47.4%, 
p<0.001) 
 
≥75 less likely to receive: beta blockers (58% vs 
67.7%, p <0.01); statin (42% vs 55%, p<0.001); 
and G6IIb/IIIa inhibitor (16.7% v 20.7%) 
 
No difference in receipt of: unfractionated 
heparin, aspirin, CCBs, amciximab, clopidogrel, 
ticlodipine. 
 
4.  
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Aggressive treatment group mean(SD) age: 
80.9 (4.8) vs conservative mean age 79(3.2). p 
not significant. 
 
Arteriography performed in 57% of ≥75 vs 81% 
of <75. 
 
≥75: 
221 received aggressive angiography at a mean 
of 48 hours. 
343 were conservatively treated. 33% received 
late angiography after a mean of 11(SD 13) 
days. 
 
5.  
Complications after PCI: significantly more likely 
in ≥75 (p <0.05) 
Death 1.2% in ≥75 vs 0.4% in <75 
AMI 4.6% in ≥75 vs 3.2% in <75 
Urgent Revascularization 1.2% in ≥75 vs 0.4% 
in <75 
Composite Complications 7% in ≥75 vs 4.1% in 
<75 
 
6.  
30-day outcomes (no statistical tests) 
Death in 36 (6.4%) of ≥75 vs. 17 (1.7% of <75 
MI in 40 (7.1%) of ≥75 vs. 51 (5%) of <75 
Stroke in 7 (1.3%) of ≥75 vs. 5 (0.5%) of <75 
 
At 30 days, 78 (13.8%) of ≥75 patients had 1+ 
complication event vs. 71 (7%) of <75 
 
7.  
Among ≥75, significant predictors were 
Conservative v aggressive strategy (OR 2.31 
(1.20-4.48)) and non-Q-wave MI at admission 
(OR 2.27 (1.32-3.93)). 
Age (OR 1.01), sex (OR 1.25), high TIMI 
score(OR 1.31), diabetes (OR 1.60), and ST 
depression(OR 1.22) were not significant. 
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Topaz et al. 
2017 
 
≥75: 
292: 82.0 
(4.7) 
 
<75: 
1365: 57.1 
(9.5) 
1. Treatment
s 
2. Test 
results 
3. Complicati
ons (after 
PCI? 
Unclear) 
4. HRs for 
long-term 
mortality 
5. HRs for 
long-term 
mortality 
among 
cardiogeni
c shock 
patients 
 
Mean (SD) 
follow up 3.4 
(2.1) years 
Gender: 
≥75: 
166 (56.8%) male 
 
<75: 
1165 (85.3%) male 
 
p<0.01 
 
Past Medical 
History: 
≥75 were more 
likely to have 
history of: HF 
(21.6% vs 5.2%, 
p<0.01), HTN 
(70.9% vs 36.8%), 
p<0.01), MI (14.7% 
vs 9.8%, p=0.01), 
prior atrial 
fibrillation (14.4% 
vs 2.5%, p<0.01), 
diabetes (27.4% vs 
20.4%, p<0.01). 
 
<75 were more 
likely to have 
history of: smoking 
(17.5% vs 57.2%, 
p<0.01) and family 
history of ischemic 
heart disease 
(4.8% vs 20.2%, 
p<0.01). 
 
There was no 
difference in: 
hyperlipidemia. 
 
 
1.  
≥75 had significantly longer time to presentation 
(mean(SD) 512(640)min vs 333(545)min, 
p<0.01) and longer door-to-balloon time 
(mean(SD) 53.9(27)min vs 41.5(16)min, p=0.02. 
 
2.  
On angiography, ≥75 were more likely to have 
3-vessel disease (36% vs 32.7%, p<0.01) and 
stent thrombosis (6.2% vs 3.5%, p<0.01) 
 
≥75 had significantly lower baseline EF 
(44.9(8.6)% vs 48.1(7.7)%, p<0.01) 
 
3. 
“In-hospital complications” 
There were equal rates of in-hospital CABG 
(2.7% vs 1.8%, p=0.35), and VT/VF arrhythmia 
(6.2% vs 6.2%).  
 
≥75 were more likely to need an IABP (8.6% vs 
2.7%, p<0.01), mechanical ventilation (9.9% vs 
3.3%, p<0.01), have bradycardia (6.8% vs 
2.3%, p<0.01), or atrial fibrillation (9.9% vs 
2.6%, p<0.01) 
 
4. 
Age ≥75 was associated with HR(95% CI) of 
3.29 (2.28-4.75), p<0.01 of “long-term mortality”, 
“controlled for all significant variables in 
univariate analysis” 
 
5. 
Among cardiogenic shock patients, HR of 30-
day mortality was not significant based on age. 
≥75 HR 2.01 (0.76-5.27) p-0.16 
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Zobel et al. 
2012 
 
[#s guessed 
from low-
resolution bar 
graph] 
 
≥80: 
about 85 
 
30-80: 
about 780 
 
<30: 
about 20 
 
[in general: 
survivors 
were slightly 
younger than 
those who 
died in 
hospital: 65.3 
vs 68.6yrs, 
p<0.002] 
1. Descriptive 
Analysis 
only 
Gender: 
≥80: 
“#male & female 
was similar” 
 
30-80: 
“# male was twice 
#female” 
 
<30: 
“# male & female 
similar” 
 
No age-based results other than descriptive 
analyses to the left. 
 
 
Discussion 
Summary 
 Overall, no American studies fitting our main search criteria (Q1) were found: both 
eligible studies were set in other countries (France and Brazil). No studies answering Q1 among 
an overall, all-diagnosis CICU population were identified. Expanding our search to secondary 
results and alternative age cutoffs found 7 additional studies, none of which were set in the US. 
Overall, the evidence varied in terms of potential for bias and applicability to current practice. 
For example, most studies were over a decade old, a time period that can translate to major 
shifts in usual care and capability in the rapidly-evolving cardiac intensive care setting. Results 
themselves included a range of different sub-populations and outcomes, limiting the ability to 
compare results across studies.  
 
	 61	
Limitations 
This preliminary systematic review is limited by the fact that a single reviewer performed 
article screening and data extraction. Although our database search was thorough, it is possible 
that the most recent articles that have not yet been indexed in PubMed. Finally, we did not 
directly contact study authors to clarify questions. Searches that extended to grey literature 
(e.g., conference abstracts) and contacting authors of studies on this topic for additional 
information may have identified additional relevant studies.  
A future systematic review study should consider including studies investigating patient 
populations that would presumably be treated in a CICU (such as post-catheterization or post-
CABG patients). This systematic review had to rule out many studies that specifically looked at 
PCI or CABG populations over 80 years but did not specify the ICU setting. 
Conclusions  
There is clear need for further research on the very elderly CICU population, both to 
describe these patients and to examine their outcomes. This need is particularly apparent in the 
US healthcare system where there are currently no published studies on this topic. Worldwide, 
there is still a dearth of literature on this subject, especially in all-diagnosis CICU populations 
rather than just the sub-population with ACS.  
 
Funding: There are no disclosures to report. 
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Appendix A.2: Search Strategy  
Pubmed: ((cardiac[ti] OR coronary[ti]) AND outcome*[ti] AND elder*[ti]) OR (((aged, 80 and 
over[mesh] OR elder*[tiab] OR geriatric*[tiab] OR octogenarian*[tiab])) AND ("Outcome 
Assessment (Health Care)"[Mesh] OR "Patient Outcome Assessment"[Mesh] OR "Outcome and 
Process Assessment (Health Care)"[Mesh] OR "length of stay" OR mortality[tiab] OR 
morbidity[tiab] OR discharge*[tiab] OR outcome*[tiab]) AND ((intensive Care Units[Mesh] OR 
Icu[tiab] OR "intensive care") AND (cardiac[ti] OR coronary[ti]) OR ("coronary Care Units"[Mesh] 
OR ccu[tiab] OR cicu[tiab] OR "coronary care"))) 
 
Embase: (cardiac:ti OR coronary:ti) AND outcome*:ti AND elder*:ti OR (('aged, 80' AND 'over' 
OR elder*:ti,ab OR geriatric*:ti,ab OR octogenarian*:ti,ab) AND ('outcome assessment (health 
care)'/exp OR 'patient outcome assessment'/exp OR 'outcome and process assessment (health 
care)'/exp OR 'length of stay'/exp OR 'length of stay' OR mortality:ti,ab OR morbidity:ti,ab OR 
discharge*:ti,ab OR outcome*:ti,ab) AND (('intensive care units'/exp OR icu:ti,ab OR 'intensive 
care'/exp OR 'intensive care') AND (cardiac:ti,ab OR coronary:ti,ab) OR 'coronary care 
units'/exp OR ccu:ti,ab OR cicu:ti,ab OR 'coronary care'/exp OR 'coronary care')) 
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Appendix A.3: Critical Appraisal Template 
Citation  
Study Question and 
Research Design 
  
Source Population  
 
Study Population 
(Descriptive: 
demographics, 
eligibility criteria) and 
how chosen 
(volunteers, 
recruitment, tertiary 
care clinics, 
population-based, 
etc.) 
 
Initial Comparability of 
groups (including 
randomization or 
method of group 
assignment; group 
composition; 
allocation 
concealment) 
 
Drop outs (no 
endpoint data, 
adherence, x-overs, 
attrition, Loss to 
follow-up) 
 
Potential for selection 
bias (low med high 
and explain) 
 
Measurement (of 
exposure/intervention; 
outcomes; potential 
confounders): 
reliability and validity 
of measurement 
instruments; how 
measurements were 
performed; include 
blinding, if needed 
 
Potential for 
measurement bias 
(rate as Low, 
Medium, or High, and 
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explain) 
Potential confounders 
(name what they are 
and how each was 
controlled: i.e., by 
randomization, 
restriction, statistical 
adjustment, 
stratification, etc.) 
 
Potential for 
confounding (rate as 
Low, Medium, or 
High, and explain) 
 
Analysis (intention to 
treat if applicable, 
other adjustment, 
etc.) 
 
Overall judgment of 
Risk of bias/internal 
validity (good, fair, or 
poor – explain) 
 
 
Applicability (external 
validity): To whom do 
the results apply? 
 
Results:  Magnitude 
and direction (point 
estimate); Sertainty/ 
random 
error/precision 
(confidence interval); 
statistical significance 
 
Singificance/ 
Clinical/public health 
importance of the 
result (explain) for the 
source population and 
wider populations 
  
Comments and your 
interpretation of the 
information from the 
study (include 
consistency with other 
studies if you can)  
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Appendix B. APACHE II Score and SAPS II Scoring Systems for Illness Severity 
 
Image source: http://www.cardiac-icu.org/APACHE.html  
Adapted from: Knaus	WA,	Draper	EA,	Wagner	DP,	Zimmerman	JE.	APACHE	II:	a	severity	of	
disease	classification	system.	Crit	Care	Med.	1985;13(10):818-829.	
http://www.ncbi.nlm.nih.gov/pubmed/3928249.	Accessed	June	3,	2018.	
 
	 66	
SAPS II Score 	
Item Points 
Age, years 
 
<40 
40-59 
60-69 
70-74 
75-79 
80+ 
 
 
0 
7 
12 
15 
16 
18 
Heart Rate 
 
 
 
<40 
40-69 
70-119 
120-159 
160+ 
* If patient had both cardiac arrest (11 points) 
and extreme tachycardia (7 points), assign 11 
points 
 
+11 
+2 
0 
+4 
+7 
Systolic BP: Worst value in 24 hours 
 
<70 
70-99 
100-199 
200+ 
 
 
+13 
+5 
0 
+2 
Temperature 39C+ (highest in 24 hours) 
 
No 
Yes 
 
 
0 
+3 
Glasgow Coma Scale (lowest in 24 hours. If 
sedated, estimated GCS before sedation) 
 
14-15 
11-13 
9-10 
6-8 
<6 
 
 
 
0 
+5 
+7 
+13 
+26 
Pa02 / Fi02 if on mechanical ventilation or 
CPAP (lowest in 24 hours; if extubated <24 
hours ago, lowest while ventilated) 
 
<100mmHg/% (13.3 kPa/%) 
100-199mmHg/% (13.3-26.5 kPa/%) 
200+mmHg/% (26.6 kPa/%) 
Not on mechanical ventilation or CPAP within 
last 24 hours 
 
 
 
 
+11 
+9 
+6 
0 
BUN, mg/dL or serum area, mmol/L (worst in 
24 hrs.) 
 
BUN <28 or urea <10 
 
 
 
0 
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BUN 28-83 or urea 10-29.6 
BUN 84+ or urea 30+ 
+6 
+10 
Urine output, mL/day (If in ICU <24 hours, 
calculate for 24 hours (e.g. if 1 L in 8 hours, 
then mark 3 L in 24 hours) 
 
<500 
500-999 
1000+ 
 
 
 
 
+11 
+4 
0 
Sodium, mEq/L (worst in 24 hours) 
 
<125 
125-144 
145+ 
 
 
+5 
0 
+1 
Potassium, mEq/L (worst in 24 hours) 
 
<3.0 
3.0-4.9 
5.0+ 
 
 
+3 
0 
+3 
Bicarbonate, mEq/L (lowest in 24 hours) 
 
<15 
15-19 
20+ 
 
 
+6 
+3 
0 
Bilirubin mg/dL (highest in 24 hours) 
 
<4.0 
4.0-5.9 
6.0+ 
 
 
0 
+4 
+9 
WBC, x 103/mm3 (worst in 24 hours) 
 
<1.0 
1.0-19.9 
20.0 
 
 
+12 
0 
+3 
Chronic Disease  
 
None 
Metastatic cancer 
Hematologic malignancy 
AIDS 
 
 
0 
+9 
+10 
+17 
Type of Admission (Scheduled surgical = 
surgery scheduled ≥24 hours prior; medical = 
no surgery within 1 week of admission; 
unscheduled surgical = surgery scheduled 
≤24 hours prior) 
 
Scheduled Surgical 
Medical 
Unscheduled Surgical 
 
 
 
 
 
 
0 
+6 
+8 
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(Adapted from https://www.mdcalc.com/simplified-acute-physiology-score-saps-ii and Le	Gall	JR,	
Lemeshow	S,	Saulnier	F.	A	new	Simplified	Acute	Physiology	Score	(SAPS	II)	based	on	a	
European/North	American	multicenter	study.	JAMA.	270(24):2957-2963.	
http://www.ncbi.nlm.nih.gov/pubmed/8254858.	Accessed	June	3,	2018.	
	
Appendix	C:	CAM-ICU	Scoring	System	For	ICU	Delirium	
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Adapted from Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated 
patients: validity and reliability of the confusion assessment method for the intensive care unit 
(CAM-ICU). JAMA. 2001;286(21):2703-2710. 
Images source: https://sites.duke.edu/micu/education/pain-agitation-and-delirium/  
 
Appendix D: Sensitivity Analyses: Testing Inclusion of Additional Comorbidities and 
Delirium 
Methods: 
 Due to limitations on the number of covariates statistically appropriate for our regression 
models, we tested several additional potential confounders (DM, CVA, CLD and delirium) by 
adding them individually to our baseline model (with the top three comorbidities we felt were 
most likely to be confounders: CAD, CHF and ESRD). We considered the possibility that DM 
and ESRD may be closely related, but their interaction coefficient was only 0.07, so they were 
inclued as separate covarites rather than as an interaction term. We established a pre-
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determined threshhold that the comorbidity should be included in our main model if the age-
associated coefficient or odds ratio changed by ≥10% after addition of the comorbidity. As an 
additional tool for comparing linear regression models (CICU and Hospital LOS), we used 
adjusted R-squared to compare model fit between our baseline model and those with additional 
comorbidities, because this test of fit adjusts for the number of covariates.  
	 The presence of delirium was strongly expected to be a confounder, but unfortunately 
our database’s measurement of CAM-ICU score was potentially biased due to irregular timing of 
administration, thus it was instead included as a sensitivity analysis. Because it was not 
administered within 24 hours of CICU admission, our CAM-ICU results do not distinguish 
between incident and prevalent delirium and are not comparable to CAM-ICU scores across the 
wider literature. In our dataset, a positive CAM-ICU score simply indicates that the patient was 
delirious at some point during their CICU admission. Nevertheless, the authors felt it was 
important to include a sensitivity analysis testing delirium’s effect on the age-mortality 
relationship, interpreting results cautiously given the potential bias.  
CAM-ICU scores were missing for 11.8% (79) patients, so a dichotomous variable 
indicating CAM-ICU “missingness” was created and found that delirium status was not missing 
at random. Thus, to control for possible bias introduced by missing data patterns, delirium was 
modeled using both “complete case analysis” (only complete cases) and multiple imputation 
(predicting values for missing cases). Both approaches were used because so we could 
compare their odds ratios against each other as an indicator of how much the imputation 
process added to the model.   
To create our multiply imputed dataset, we imputed CAM-ICU based on the variables 
that were most significantly associated with missingness (BMI, age (continuous), sex, race, 
therapeutic hypothermia, primary admission diagnosis of cardiogenic shock or PEA/Asystolic 
arrest, SAPS II Score, past medical history of: [CAD, MI, cancer within 5 years, LVAD], and 
receipt of: [diagnosic catheterization, PCI, PA Catheter, vasopressors, inotropes, ICD, ECMO, 
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and endoscopy]). We avoided including two variables that were highly correlated or measured 
similar characteristics (i.e. we only included SAPS II, not APACHE II). We also included the 
most detailed level of a variable available—such as 5-category race and continuous age rather 
than the dichotomized versions. CAM ICU was imputed in logit form for mortality analyses, and 
was imputed using linear regression for LOS analyses. 
50 imputed datasets were created, such that when we performed regression using the 
imputed CAM-ICU variable, STATA ran 50 regressions using each imputed dataset. The 
distribution of each of these 50 results was used to predict the “true” single value for each 
regression output.  
Results: Addition of Diabetes, CVA or CLD 
Neither DM, CVA nor CLD were significantly associated with LOS or mortality in the 
CICU or in the hospital. Additionally, none of these three comorbidities added significantly to the 
age-LOS association for any of these four outcomes (the change in age-associated 
coefficient/OR was <10%). Adding any of these additional comorbidities did not change model 
fit compared to our baseline model controlling for just CAD, CHF and ESRD (adjusted R-
Squared =0.14 for hospital LOS, 0.10 for CICU LOS) (Tables D.1 through D.6). 
One notable change is that adding DM to the model strengthened the relationship 
between ESRD and hospital LOS. (Table D.3).  
	
Table	D.1	Univariate	(Unadjusted)	LOS	Coefficients	
Variable	 Hospital	LOS:	
Coefficient	
p	 CICU	LOS:	
Coefficient	
p	
Diabetes	Mellitus	(DM)	 0.14	(-1.74-2.02)	 0.88	 0.19	(-0.71-1.10)	 0.68	
Cerebrovascular	Accident	(CVA)	 -0.73	(-3.53-2.08)	 0.61	 0.04	(-1.31-1.40)	 0.95	
Chronic	Lung	Disease	(CLD)	 0.97	(-1.20-3.15)	 0.38	 0.43	(-0.63-1.48)	 0.43	
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Table	D.2	CICU	LOS:	Sensivity	Analysis	with	Additional	Comorbidities	(among	CICU	survivors,	n=593)	
Variable Add DM Add CVA Add CLD 
 Coefficient p Coefficient p Coefficient p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
-0.72 (-1.98-0.54) 
 
 
0.27 
 
-- 
-0.68 (-1.92-0.56) 
 
 
0.28 
 
-- 
-0.68 (-1.93-0.56) 
 
 
0.28 
Sex 
   Female (ref) 
   Male 
 
-- 
-0.32 (-1.20-0.55) 
 
 
0.47 
 
-- 
-0.29 (-1.16-0.58) 
 
 
0.51 
 
-- 
0.31 (-1.18-0.57) 
 
 
0.49 
BMI (per kg/m2) 0.001 (-0.05-0.06) 0.96 -0.001 (-0.06-0.05) 0.97 -0.001 (-0.06-0.05) 0.97 
Race 
   White (ref) 
   Non-white 
 
-- 
0.96 (0.09-1.84) 
 
 
0.03 
 
-- 
0.97 (0.10-1.85) 
 
 
0.03 
 
-- 
0.97 (0.10-1.85) 
 
 
0.03 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.99 (0.15-1.83) 
 
 
0.02 
 
-- 
0.99 (0.15-1.83) 
 
 
0.02 
 
-- 
0.98 (0.14-1.82) 
 
 
0.02 
Age-Adjusted 
SAPS II Score 
(per 1 unit) 
0.08 (0.05-0.11) <0.001 0.08 (0.05-0.11) <0.001 0.08 (0.05-0.11) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
   DM 
   CVA 
   Chronic Lung     
      Disease 
 
0.07 (-0.82-0.96) 
1.96 (1.10-2.81) 
-0.25 (-1.94-1.44) 
-0.20 (-1.12-0.73) 
 
0.88 
<0.001 
0.77 
0.68 
 
0.02 (-0.86-0.89) 
1.95 (1.10-2.81) 
-0.27 (-1.95-1.41) 
 
0.20 (-1.10-1.50) 
 
0.97 
<0.001 
0.75 
 
0.76 
 
0.03 (-0.84-0.91) 
1.96 (1.10-2.83) 
-0.28 (-1.97-1.40) 
 
 
-0.07 (-1.10-0.96) 
 
0.94 
<0.001 
0.74 
 
 
0.89 
Constant 0.78 0.45 0.76 0.46 0.81 0.43 
Adjusted R2 0.09  0.09  0.09  
% Change from -
0.68 (Table 5) 
5.88%  
away from null 
 0.0%  0.0%  
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Table	D.3	Hospital	LOS:	Sensitivity	Analysis	with	Additional	Comorbidities	(among	hospital	survivors,	n=570)	
Variable Add DM Add CVA Add CLD 
 Coefficient p Coefficient p Coefficient p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
-2.39 (-4.96-0.17) 
 
 
0.07 
 
-- 
-2.28 (-4.81-0.25) 
 
 
0.08 
 
-- 
-2.30 (-4.84-0.23) 
 
 
0.08 
Sex 
   Female (ref) 
   Male 
 
-- 
0.02 (-1.76-1.80) 
 
 
0.98 
 
-- 
0.08 (-1.70-1.85) 
 
 
0.93 
 
-- 
0.04 (-0.75-1.83) 
 
 
0.97 
BMI (per kg/m2) -0.03 (-0.14-0.09) 0.66 -0.03 (-0.15-0.08) 0.56 -0.03 (-0.14-0.08) 0.57 
Race 
   White (ref) 
   Non-white 
 
-- 
0.58 (-1.19-2.36) 
 
 
0.52 
 
-- 
0.61 (-1.16-2.39) 
 
 
0.50 
 
-- 
0.61 (-1.17-2.38) 
 
 
0.50 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
3.23 (1.52-4.95) 
 
 
<0.001 
 
-- 
3.21 (1.49-4.92) 
 
 
<0.001 
 
-- 
3.20 (1.49-4.92) 
 
 
<0.001 
Age-Adjusted 
SAPS II Score 
(per 1 unit) 
0.21 (0.14-0.27) <0.001 0.21 (0.14-0.27) <0.001 0.21 (0.14-0.27) 0.16 
History of: 
   CAD 
   CHF 
   ESRD 
   DM 
   CVA 
   Chronic Lung     
      Disease 
 
-1.18 (-2.99-0.62) 
5.61 (3.87-7.34) 
-2.44 (-5.89-1.02) 
-0.50 (-2.39-1.39) 
 
 
 
0.20 
<0.001 
0.17 
0.60 
 
-1.29 (-3.06-0.49) 
5.61 (3.89-7.34) 
-2.51 (-5.96-0.94) 
 
-0.06 (-2.70-2.58) 
 
 
0.16 
<0.001 
0.97 
 
0.15 
 
-1.27 (-3.04-0.50) 
5.64 (3.89-7.40) 
-2.52 (-5.97-0.93) 
 
 
-0.33 (-2.41-1.75) 
 
0.16 
<0.001 
0.76 
 
 
0.15 
Constant 2.30 0.28 2.36 0.27 2.39 0.26 
Adjusted R2 0.14  0.14  0.14  
% Change from -
2.28 (Table 6) 
4.82%  
away from null 
 0.0%  0.88% 
away from null 
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Table	D.4:	CICU	Mortality	Sensitivity	Analysis,	Testing	Additional	Comorbidities	
Variable Add DM Add CVA Add CLD 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
1.07 (0.48-2.36) 
 
 
0.87 
 
-- 
1.06 (0.48-2.30) 
 
 
0.89 
 
-- 
1.12 (0.51-2.45) 
 
 
0.77 
Sex 
   Female (ref) 
   Male 
 
-- 
0.76 (0.42-1.37) 
 
 
0.36 
 
-- 
0.76 (0.42-1.38) 
 
 
0.37 
 
-- 
0.75 (0.41-1.35) 
 
 
0.34 
BMI (per kg/m2) 0.97 (0.93-1.01) 0.12 0.97 (0.93-1.01) 0.11 0.97 (0.93-1.01) 0.11 
Race 
   White (ref) 
   Non-white 
 
-- 
0.77 (0.41-0.44) 
 
 
0.41 
 
-- 
0.75 (0.40-1.39) 
 
 
0.36 
 
-- 
0.79 (0.43-1.48) 
 
 
0.46 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.84 (0.47-1.53) 
 
 
0.59 
 
-- 
0.86 (0.48-1.55) 
 
 
0.62 
 
-- 
0.85 (0.47-1.54) 
 
 
0.59 
Age-Adjusted SAPS  
   II Score (per 1 unit) 
1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
   DM 
   CVA 
   Chronic Lung     
      Disease 
 
1.56 (0.83-2.94) 
1.02 (0.56-1.85) 
1.35 (0.56-3.28) 
1.07 (0.55-2.05) 
	
 
0.17 
0.96 
0.50 
0.85 
 
1.56 (0.85-2.88) 
1.03 (0.57-1.88) 
1.31 (0.54-3.20) 
 
1.35 (0.58-3.15) 
 
0.15 
0.91 
0.55 
 
0.49 
 
1.56 (0.84-2.88) 
0.99 (0.54-1.81) 
1.31 (0.53-3.24) 
 
 
1.58 (0.83-2.99) 
 
0.16 
0.98 
0.55 
 
 
0.16 
Constant 0.028 <0.001 0.027 <0.001 0.025 <0.001 
Pseudo R2 0.31  0.31  0.31  
% Change from 1.05 
(Table 7) 
+1.90%  +0.95%  +6.67%  
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Table	D.5:	Sensitivity	Analysis	for	Hospital	Mortality,	Testing	Alternative	Comorbidities	
Variable Add DM Add CVA Add CLD 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
1.22 (0.59-2.51) 
 
 
0.59 
 
-- 
1.21 (0.60-2.46) 
 
 
0.60 
 
-- 
1.23 (0.60-2.49) 
 
 
0.57 
Sex 
   Female (ref) 
   Male 
 
-- 
0.58 (0.34-1.00) 
 
 
0.05 
 
-- 
0.59 (0.34-1.01) 
 
 
0.05 
 
-- 
0.58 (0.34-0.99) 
 
 
0.05 
BMI (per kg/m2) 0.99 (0.95-1.02) 0.49 0.99 (0.95-1.02) 0.49 0.99 (0.95-1.02) 0.50 
Race 
   White (ref) 
   Non-white 
 
-- 
0.95 (0.54-1.66) 
 
 
0.85 
 
-- 
0.92 (0.53-1.61) 
 
 
0.77 
 
-- 
0.95 (0.54-1.66) 
 
 
0.86 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
1.45 (0.82-2.56) 
 
 
0.17 
 
-- 
1.49 (0.87-2.55) 
 
 
0.15 
 
-- 
1.45 (0.85-2.48) 
 
 
0.17 
Age-Adjusted SAPS  
   II Score (per 1 unit) 
1.08 (1.07-1.10) <0.001 1.10 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
   DM 
   CVA 
   Chronic Lung     
      Disease 
 
1.45 (0.82-2.56) 
1.09 (0.63-1.87) 
0.98 (0.42-2.30) 
1.05 (0.58-1.90) 
 
 
0.21 
0.77 
0.96 
0.88 
 
1.44 (0.82-2.50) 
1.10 (0.64-1.89) 
0.94 (0.39-2.23) 
 
1.46 (0.67-3.18) 
 
0.20 
0.74 
0.89 
 
0.34 
 
1.46 (0.84-2.54) 
1.08 (0.63-1.87) 
 0.97 (0.41-2.30) 
 
 
1.14 (0.62-2.09) 
 
0.18 
0.78 
0.95 
 
 
0.67 
Constant 0.019  <0.001 0.018 <0.001 0.018 <0.001 
Pseudo R2 0.30  0.30  0.30  
% Change from 1.21 
(Table 8) 
0.83%  0.0%  +1.65%  
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Table	D.6:	Univariate	(Unadjusted)	Odds	Ratios	for	Mortality	
Variable	 CICU	Mortality:	
OR	(95%	CI)	
p	 Hospital	Mortality:	
OR	(95%	CI)	
p	
Diabetes	Mellitus	(DM)	 1.16	(0.71-1.90)	 0.45	 1.16	(0.75-1.80)	 0.51	
Cerebrovascular	Accident	(CVA)	 1.13	(0.56-2.31)	 0.73	 1.17	(0.62-2.22)	 0.63	
Chronic	Lung	Disease	(CLD)	 1.66	(0.99-2.80)	 0.06	 1.29	(0.79-2.11)	 0.31	
	
Results:	Addition	of	Delirium	
Overall, age-based coefficients and ORs were not different comparing a complete case 
analysis approach to the imputed data, with the exception of hospital mortality. Because 
imputation used the full patient sample, and did not change age-based results into a 
counterintuitive numbers, we expect that the multiply imputed models are likely closer to the true 
value for all four regression outcomes than the complete case analysis. 
Delirium (at any point during the CICU stay) did not contribute significantly to models 
between age and CICU or hospital LOS (age-based coefficient changed <10%). It was, 
however, significantly related to both CICU and hospital LOS when controlled for demographics 
and clinical variables: patients with documented ICU delirium stayed 1.4 more days in the CICU 
and 2.9 more days in the hospital, compared to those with a negative CAM-ICU. In the end, 
controlling for delirium did not change our baseline model conclusions or the significance of any 
other model covariates. Our data suggests that very elderly patients do not have longer lengths 
of stay, regardless of delirium status (Tables D.7 and D.8).  
Delirium explained a significant portion of the relationship between age and CICU 
mortality, reducing the age-based OR by 11.43% to 0.93 (0.41-2.14, p=0.87), but did not alter 
the conclusion that there is no difference in CICU mortality by age group. In fact, controlling for 
delirium reversed the (insignificant) odds ratio trend to associate older age with lower odds of 
CICU mortality (Table D.9). However, when multiple imputation is used to calculate predicted 
probabilities of CICU mortality, the very elderly still display an insignificant trend of higher 
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mortality rates (Figure D.1). Figure D.1 demonstrates that delirium significantly increases the 
predicted probability of mortality in those <80, but not in the very elderly. 
  
Figure	D.1:	Predicted Probability of CICU Mortality by Age and Delirium (adjusted for BMI, 
sex, race, age-adjusted SAPS II Score, ICU model type, and history of CAD, CHF and 
ESRD, using multiply imputed delirium data.	
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Table	D.7:	CICU	LOS	and	Delirium	
Variable Univariate Multiply Imputed CAM 
ICU 
N=593 
Complete Case Analysis 
N=545 
 Coefficient p Coefficient p Coefficient p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
0.82 (-2.09-0.45) 
 
 
0.21 
 
-- 
-0.71 (-1.95-0.53) 
 
 
0.26 
 
-- 
-0.67 (-1.97-0.64) 
 
 
0.32 
Sex 
   Female (ref) 
   Male 
 
-- 
-0.17 (-1.07-0.72) 
 
 
0.70 
 
-- 
-0.24 (-1.11-0.62) 
 
 
0.58 
 
-- 
-0.33 (-1.25-0.59) 
 
 
0.49 
BMI (per kg/m2) 0.03 (-0.03-0.09) 0.29 0.004 (-0.05-0.06) 0.89 -0.002 (-0.06-0.06) 0.94 
Race 
   White (ref) 
   Non-white 
 
-- 
1.67 (0.81-2.53) 
 
 
<0.001 
 
-- 
0.96 (0.09-1.84) 
 
 
0.03 
 
-- 
1.10 (0.17-2.03) 
 
 
0.02 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.52 (-0.35-1.38) 
 
 
0.24 
 
-- 
0.92 (0.09-1.76) 
 
 
0.03 
 
-- 
1.03 (0.15-1.92) 
 
 
0.02 
Age-Adjusted SAPS  
   II Score (per 1 unit) 
0.09 (0.06-0.12) <0.001 0.07 (0.04-0.10) <0.001 0.07 (0.04-0.11) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
0.12 (-0.74-0.99) 
2.22 (1.38-3.07) 
1.08 (-0.64-2.81) 
 
0.78 
<0.001 
0.22 
 
0.06 (-0.80-0.93) 
1.97 (1.11-2.82) 
-0.24 (-1.92-1.44) 
 
0.89 
<0.001 
0.78 
 
0.03 (-0.90-0.95) 
2.03 (1.12-2.93) 
-0.22 (-2.01-1.57)	
 
0.96 
<0.001 
0.81 
Delirium (CAM-ICU) 
   Negative (ref) 
   Positive 
 
-- 
2.83 (1.60-4.05) 
 
 
<0.001 
 
-- 
1.39 (0.13-2.64) 
 
 
0.03 
 
-- 
1.60 (0.30-2.89) 
 
 
0.02 
Constant   0.72 0.49 1.00 0.35 
% Change from -0.68 
(Table 5) 
  4.41% away from 
null 
 1.47% toward null  
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Table	D.8:	Hospital	LOS	and	Delirium	
Variable Univariate Multiply Imputed CAM 
ICU 
N=570 
Complete Case Analysis 
N=526 
 Coefficient p Coefficient p Coefficient p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
-2.21 (-4.86-0.44) 
 
 
0.10 
 
-- 
-2.38 (-4.90-0.14) 
 
 
0.06 
 
-- 
-2.39 (-4.91-0.14) 
 
 
0.06 
Sex 
   Female (ref) 
   Male 
 
-- 
0.58 (-1.27-2.44) 
 
 
0.62 
 
-- 
0.23 (-1.53-2.00) 
 
 
0.80 
 
-- 
-0.21 (-1.99-1.58) 
 
 
0.82 
BMI (per kg/m2) 0.03 (-0.09-0.15) 0.63 -0.02 (-0.13-0.09) 0.70 -0.05 (-0.16-0.07) 0.43 
Race 
   White (ref) 
   Non-white 
 
-- 
2.41 (0.60-4.21) 
 
 
0.009 
 
-- 
0.60 (-1.17-2.36) 
 
 
0.51 
 
-- 
0.87 (-0.92-2.67) 
 
 
0.34 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
1.60 (-0.19-3.39) 
 
 
0.08 
 
-- 
3.02 (1.31-4.74) 
 
 
0.001 
 
-- 
3.63 (1.90-5.35) 
 
 
<0.001 
Age-Adjusted SAPS  
   II Score (per 1 unit) 
0.20 (0.14-0.28) <0.001 0.17 (0.10-0.25) <0.001 0.17 (0.10-0.24) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
-1.29 (-3.06-0.47) 
5.60 (3.87-7.34) 
-2.51 (-5.95-0.94) 
 
0.15 
<0.001 
0.15 
 
-1.23 (-2.99-0.53) 
5.61 (3.88-7.34) 
-2.47 (-5.91-0.96) 
 
0.17 
<0.001 
0.16 
 
-0.96 (-2.47-0.82) 
5.71 (3.95-7.46) 
-2.06 (-5.57-1.45) 
 
0.29 
<0.001 
0.25 
Delirium (CAM-ICU) 
   Negative (ref) 
   Positive 
 
-- 
6.22 (3.74-8.70) 
 
 
<0.001 
 
-- 
2.91 (0.20-5.62) 
 
 
0.04 
 
-- 
3.39 (0.82-5.96) 
 
 
0.01 
Constant   2.20 0.30 2.55 0.23 
% Change from -2.28 
(Table 6) 
  4.39%  
away from null 
 4.82% 
away from null 
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Table	D.9:	CICU	Mortality	and	Delirium	
Variable Univariate Multiply Imputed CAM 
ICU 
N=670 
Complete Case Analysis 
N=591 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
1.06 (0.48-2.30) 
 
 
0.89 
 
-- 
0.93 (0.41-2.14) 
 
 
0.87 
 
-- 
0.93 (0.35-2.42) 
 
 
0.88 
Sex 
   Female (ref) 
   Male 
 
-- 
0.76 (0.42-1.38) 
 
 
0.37 
 
-- 
0.80 (0.43-1.49) 
 
 
0.49 
 
-- 
0.73 (0.36-1.50) 
 
 
0.39 
BMI (per kg/m2) 0.97 (0.93-1.01) 0.11 0.98 (0.94-1.02) 0.28 0.98 (0.94-1.03) 0.48 
Race 
   White (ref) 
   Non-white 
 
-- 
0.75 (0.40-1.39) 
 
 
0.36 
 
-- 
0.76 (0.40-1.44) 
 
 
0.40 
 
-- 
0.82 (0.39-1.72) 
 
 
0.60 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.86 (0.48-1.55) 
 
 
0.62 
 
-- 
0.76 (0.41-1.41) 
 
 
0.38 
 
-- 
0.71 (0.35-1.46) 
 
 
0.36 
Age-Adjusted SAPS  
   II Score (per 1 unit) 
1.08 (1.06-1.10) <0.001 1.07 (1.05-1.09) <0.001 1.05 (1.03-1.07) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
1.20 (0.75-1.94) 
0.90 (0.56-1.44) 
2.30 (1.13-4.71) 
 
0.45 
0.66 
0.02 
 
1.63 (0.86-3.07) 
1.03 (0.56-1.92) 
1.33 (0.54-3.24) 
 
0.13 
0.92 
0.53 
 
1.62 (0.79-3.33) 
1.22 (0.59-2.50) 
1.46 (0.53-4.02) 
 
0.19 
0.59 
0.46 
Delirium (CAM-ICU) 
   Negative (ref) 
   Positive 
 
-- 
13.63 (7.35-25.28) 
 
 
<0.001 
 
-- 
4.70 (2.33-9.48) 
 
 
<0.001 
 
-- 
5.70 (2.73-11.91) 
 
 
<0.001 
Constant   0.018 <0.001 0.017 <0.001 
% Change from 1.05 
(Table 7) 
  -11.43%  -11.43%  
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Table	D.10:	Hospital	Mortality	and	Delirium	
Variable Univariate Multiply Imputed CAM 
ICU 
N=670 
Complete Case 
Analysis 
N=591 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age 
   <80 years (ref) 
   ≥80 years 
 
-- 
1.49 (0.85-2.63) 
 
 
0.17 
 
-- 
1.14 (0.54-2.40) 
 
 
0.74 
 
-- 
1.07 (0.46-2.49) 
 
 
0.87 
Sex 
   Female (ref) 
   Male 
 
-- 
0.70 (0.45-1.08) 
 
 
0.10 
 
-- 
0.62 (0.36-1.08) 
 
 
0.09 
 
-- 
0.57 (0.31-1.06) 
 
 
0.07 
BMI (per kg/m2) 1.00 (0.98-1.03) 0.89 1.00 (0.96-1.03) 0.88 1.00 (0.96-1.04) 0.93 
Race 
   White (ref) 
   Non-white 
 
-- 
1.03 (0.67-1.58) 
 
 
0.90 
 
-- 
0.94 (0.53-1.68) 
 
 
0.84 
 
-- 
0.94 (0.50-1.78) 
 
 
0.86 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
1.08 (0.70-1.65) 
 
 
0.73 
 
-- 
1.38 (0.80-2.41) 
 
 
0.25 
 
-- 
1.27 (0.68-2.34) 
 
 
0.45 
Age-Adjusted SAPS  
   II Score (per 1 unit) 
1.08 (1.07-1.10) <0.001 1.07 (1.05-1.09) <0.001 1.05 (1.03-1.07) <0.001 
History of: 
   CAD 
   CHF 
   ESRD 
 
1.11 (0.72-1.71) 
0.93 (0.61-1.43) 
1.91 (0.96-3.79) 
 
0.62 
0.75 
0.07 
 
1.49 (0.84-2.63) 
1.10 (0.63-1.93) 
0.96 (0.41-2.25) 
 
0.17 
0.74 
0.92 
 
1.52 (0.82-2.86) 
1.22 (0.65-2.27) 
1.17 (0.46-2.97) 
 
0.19 
0.54 
0.74 
Delirium (CAM-ICU) 
   Negative (ref) 
   Positive 
 
-- 
11.31 (6.71-19.06) 
 
 
<0.001 
 
-- 
3.82 (2.08-7.01) 
 
 
<0.001 
 
-- 
4.24 (2.26-7.98) 
 
 
<0.001 
Constant   0.013 <0.001 0.015 <0.001 
% Change from 1.21 
(Table 8) 
  -5.79%  -11.57%  
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Appendix	E:	Sensitivity	Analysis	Testing	Age	as	Quadratic	and	Spline	Constructions	
Results were compared to dichotomous reduced models by qualitatively assessing 
trends and quantitatively assessing model fit using adjusted or pseudo R-squared values. If 
coefficients or odds ratios suggested considerably different trends than our dichotomous model, 
it would be interpreted that perhaps an alternative way of modeling age should be considered 
when evaluating the very elderly. 
Considering age in alternative forms did not improve model fit for any of our four 
outcomes (CICU LOS, Hospital LOS, CICU Mortality, and Hospital Mortality). LOS coefficients 
supported our conclusion that age is not associated with different admission length, and 
potentially even shorter hospital stays (Tables E.1 and E.2). In spline models for each year of 
age after 40, insignificant trends suggested potentially shorter CICU and hospital stays, while 
increasing age before 40 was associated with significantly longer CICU and hospital stays 
(Tables E.1 and E.2, Figure E.2). The quadratic model found that increasing age was 
associated with significantly shorter hospital stays (Figure E.1), but no difference was seen by 
age-squared for CICU LOS (Table E.1). Mortality coefficients did not find significant age-based 
variation in any of the four spline categories of age, nor when considering age squared (Tables 
E.3 and E.4).  
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Table	E.1:	Alternatve	Age	Models	for	CICU	LOS	
Variable Univariate Model A8: Age Quadratic Model A9: Age Splined 
 Coefficient p Coefficient p Coefficient p 
Age2   -0.001 (-0.003-7e-6) 0.05   
Age Splined 
   <40 
   40-60 
   60-80 
   80+ 
 
0.16 (0.005-0.32) 
-0.05 (-0.15-0.04) 
-0.01 (-0.09-0.07) 
-0.08 (-0.32-0.16) 
 
0.04 
0.29 
0.74 
0.53 
 
 
  
0.18 (0.02-0.33) 
-0.04 (-0.13-0.05) 
-0.02 (-0.09-0.06) 
-0.05 (-0.28-0.18) 
 
0.03 
0.38 
0.68 
0.67 
Sex 
   Female (ref) 
   Male 
 
-- 
-0.17 (-1.07-0.72) 
 
 
0.70 
 
-- 
-0.36 (-1.22-0.50) 
 
 
0.41 
 
-- 
-0.34 (-1.19-0.53) 
 
 
0.45 
BMI (per kg/m2) 0.03 (-0.03-0.09) 0.29 -0.005 (-0.06-0.05) 0.86 -0.01 (-0.07-0.04) 0.70 
Race 
   White (ref) 
   Non-white 
 
-- 
1.67 (0.81-2.53) 
 
 
<0.001 
 
-- 
1.01 (0.14-1.88) 
 
 
0.02 
 
-- 
0.96 (0.09-1.83) 
 
 
0.03 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
0.52 (-0.35-1.38) 
 
 
0.24 
 
-- 
0.96 (0.12-1.79) 
 
 
0.03 
 
-- 
0.93 (0.09-1.76) 
 
 
0.03 
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
0.09 (0.06-0.12) <0.001 0.08 (0.05-0.11) <0.001 0.08 (0.05-0.11) <0.001 
History of CHF 2.22 (-0.64-2.81) <0.001 1.95 (1.12-2.79) <0.001 1.96 (1.12-2.79) <0.001 
Constant   -3.14 0.19 -5.05 0.07 
Adjusted R-
Squared 
  0.10  0.10  
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Table	E.2:	Alternative	Age	Models	for	Hospital	LOS	
Variable Univariate Model A8: Age Quadratic Model A9: Age Splined 
 Coefficient p Coefficient p Coefficient p 
Age2 -0.003 (-0.01-8e-6) 0.05 -0.003 (-0.01-(-0.0003)) 0.02   
Age Splined 
   <40 
   40-60 
   60-80 
   80+ 
 
0.29 (-0.04-0.61) 
-0.12 (-0.32-0.07) 
-0.01 (-0.18-0.15) 
-0.38 (-0.88-0.13) 
 
0.08 
0.22 
0.90 
0.14 
 
 
  
0.34 (0.03-0.65) 
-0.12 (-0.31-0.07) 
-0.03 (-0.18-0.13) 
-0.31 (-0.78-0.17) 
 
0.03 
0.20 
0.71 
0.20 
Sex 
   Female (ref) 
   Male 
 
-- 
0.58 (-1.27-2.44) 
 
 
0.62 
 
-- 
-0.33 (-2.09-1.43) 
 
 
0.93 
 
-- 
-0.26 (-2.02-1.51) 
 
 
0.77 
BMI (per kg/m2) 0.03 (-0.09-0.15) 0.63 -0.04 (-0.15-0.08) 0.54 -0.05 (-0.16-0.07) 0.42 
Race 
   White (ref) 
   Non-white 
 
-- 
2.41 (0.60-4.21) 
 
 
0.009 
 
-- 
0.73 (-1.03-2.49) 
 
 
0.51 
 
-- 
0.66 (-1.11-2.42) 
 
 
0.46 
CICU Structure 
   Open (ref) 
   Closed 
 
-- 
1.60 (-0.19-3.39) 
 
 
0.08 
 
-- 
3.05 (1.35-4.76) 
 
 
<0.001 
 
-- 
3.04 (1.32-4.75) 
 
 
0.001 
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
0.20 (0.14-0.28) <0.001 0.20 (0.13-0.26) <0.001 0.20 (0.14-0.27) <0.001 
History of CHF 5.61 (3.89-7.34) <0.001 5.33 (3.62-7.03) <0.001 5.32 (3.62-7.03) <0.001 
Constant   -5.45 (-14.86-3.96) 0.256 -8.73  0.12 
Adjusted R-
Squared 
  0.14  0.14  
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Figure	E.1:	Quadratic	Model	of	Hospital	Length	of	Stay	(p=0.02)	
	
Figure	E.2:	Spline	Model	of	Hospital	Length	of	Stay	(knotted	at	age	40,	60,	and	80	years)	
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Table	E.3:	Alternative	Age	Models	for	CICU	Mortality	
Variable Univariate Model B8: Age 
Quadratic 
Model B9: Age Splined 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age2 1.00 (1.00-1.00) 0.39 1.00 (1.00-1.00) 0.36   
Age Splined 
   <40 
   40-60 
   60-80 
   80+ 
 
1.03 (0.89-1.20) 
1.04 (0.98-1.11) 
1.02 (0.97-1.06) 
1.01 (0.90-1.13) 
 
0.70 
0.22 
0.45 
0.91 
   
1.06 (0.89-1.25) 
1.04 (0.95-1.13) 
1.01 (0.96-1.06) 
1.01 (0.87-1.18) 
 
0.54 
0.39 
0.74 
0.85 
Sex 
   Female (ref) 
   Male 
 
-- 
0.87 (0.53-1.40) 
 
 
0.56 
 
-- 
0.81 (0.45-1.47) 
 
 
0.50 
 
-- 
0.81 (0.45-1.47) 
 
 
0.49 
BMI (per kg/m2) 0.99 (0.96-1.02) 0.40 0.97 (0.93-1.01) 0.10 0.97 (0.93-1.01) 0.10 
Race 
   White (ref) 
   Non-white 
 
-- 
0.87 (0.54-1.41) 
 
 
0.57 
 
-- 
0.83 (0.45-1.50) 
 
 
0.53 
 
-- 
0.83 (0.45-1.47) 
 
 
0.53 
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
1.08 (1.06-1.10) <0.001 1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 
Constant   0.001 0.004 0.002 0.051 
Pseudo R2   0.3147  0.3145  
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Table	E.4:	Alterntaive	Age	Models	for	Hospital	Mortality	
Variable Univariate Model 8: Age Quadratic Model 9: Age Splined 
 OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age2 1.00 (1.00-1.00) 0.27 1.00 (1.00-1.00) 0.23   
Age Splined 
   <40 
   40-60 
   60-80 
   80+ 
 
1.04 (0.90-1.21) 
1.05 (0.99-1.14) 
1.01 (0.97-1.05) 
1.02 (0.92-1.13) 
 
0.58 
0.11 
0.56 
0.68 
 
 
  
1.06 (0.89-1.27) 
1.06 (0.98-1.14) 
1.00 (0.96-1.05) 
1.05 (0.92-1.19) 
 
0.49 
0.14 
0.94 
0.51 
Sex 
   Female (ref) 
   Male 
 
-- 
0.70 (0.45-1.08) 
 
 
0.10 
 
-- 
0.61 (0.36-1.04) 
 
 
0.07 
 
-- 
0.60 (0.35-1.04) 
 
 
0.07 
BMI (per kg/m2) 1.00 (0.98-1.03) 0.89 0.99 (0.96-1.03) 0.59 0.99 (0.95-1.03) 0.59 
Race 
   White (ref) 
   Non-white 
 
-- 
1.03 (0.67-1.58) 
 
 
0.90 
 
-- 
1.04 (0.61-1.79) 
 
 
0.88 
 
-- 
1.04 (0.60-1.78) 
 
 
0.90 
Age-Adjusted  
   SAPS II Score     
   (per 1 unit) 
1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 1.08 (1.07-1.10) <0.001 
Constant   0.0004 0.001 0.0008 0.03 
Pseudo R2   0.31  0.31  
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Appendix F: Details about “Other” Diagnoses 
We disagreed with the database’s existing classification of several patients who were 
coded as “other” diagnoses. (The database was originally in Excel and included a text column 
for diagnoses, which had then been coded into binary variables indicating each primary 
diagnosis.) Six patients were recoded under “Arrhythmia” [ original primary diagnoses as 
recorded: “Afib, Atrial fibrillation s/p convergent procedure, atrial fib s/p ablation, a fib s/p 
ablation with pericardial effusion, PVC, Premature Ventricular Complex” ]. One patient was 
recoded under “Tamponade or Effusion” [ original primary diagnosis as recorded: “cardiac 
tamponade and pericardial effusion”].  
Note that the very elderly exclusively had cardiac-related “other diagnoses” (listed 
below). The most common “other” diagnoses in the overall population were: ICD or pacemaker-
related (malfunctions, placements, or infections: 2 ≥80, 5 <80), takotsubo cardiomyopathy (2 
≥80, 4 <80), pulmonary hypertension (5 <80), pneumonia (4 <80), and GI bleeds (4 <80).  
Other Diagnoses in Those <80 Years Other Diagnoses in Those ≥80 Years 
NEUROLOGIC: 
1 Hypoxic Brain Injury 
1 Syncopal Event 
1 Watershed Infarct Secondary to Carotid  
   Artery Stenosis 
1 Intracranial Hemorrhage 
1 Myasthenia Gravis Exacerbation 
1 Seizures 
1 Ischemic CVA of Brainstem and NSTEMI 
1 Altered Mental Status 
 
CARDIAC: 
2 Chest Pain 
4 Takotsubo Cardiomyopathy 
2 Peripartum Cardiomyopathy 
1 Descending Aortic Aneurysm 
1 Patent Foramen Ovale 
1 “congestive heart failure, congenital heart 
disease - transposition of great vessels, s/p 
mustard procedure, pulm stenosis, vsd, with 
right to left shunt” 
1 “nstemi, sick sinus syndrome, hcap with 
sepsis, atrial fibrillation” 
 
 
 
 
 
 
 
 
 
 
 
 
CARDIAC:  
 
2 Takotsubo Cardiomyopathy 
 
 
1 Patent Foramen Ovale 
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1 ICD placement 
1 ICD leads infection 
2 ICD malfunction/misfire 
1 “chest pain secondary to stable angina and 
scarring secondary to ICD” 
2 Hypotension 
2 Cardiopulmonary collapse 
1 PVD 
 
PULMONARY: 
2 pleural effusion 
4 pneumonia  
4 pulmonary hypertension 
1 Hypoxic Respiratory Failure 
1 Shortness of Breath 
 
GASTROINTESTINAL: 
4 GI Bleeds 
 
ENDOCRINE: 
1 Hyperparathyroidism 
 
MUSCULOSKELETAL: 
1 Pelvic/lumbar back pain 
1 lower extremity hematoma 
3 non-cardiac chest pain 
 
1 morbid obesity 
 
OTHER 
1 Observation 
1 narcotic overdose 
 
2 Pacemaker Infections 
1 ICD Lead Infection 
 
 
 
 
1 Cardiopulmonary Collapse 
 
	
	
	
 
